Endocrine system disorder
MONDO:0005151A disease involving the endocrine system.
Also known as: disease of endocrine system, disease or disorder of endocrine system, disorder of endocrine system, endocrine disease, endocrine disorder, endocrine system disease, endocrine system disease or disorder, endocrine system disorder
12469 clinical trials for this condition and its sub-types, 78 tagged with Endocrine system disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Endocrine system disorder
-
Pancreas disorder 44 trials · 5,580 incl. sub-types
14 sub-types
- Endocrine pancreas disorder 1 trial · 3,923 incl. sub-types Sub-types →
- Pancreatic neoplasm 926 trials · 1,573 incl. sub-types Sub-types →
- Pancreatitis 120 trials · 203 incl. sub-types Sub-types →
- Exocrine pancreatic insufficiency 29 trials Sub-types →
- Recurrent acute pancreatitis 19 trials
- Accessory pancreas 0 trials
- Acinar cystic transformation of the pancreas 0 trials
- Annular pancreas 0 trials
- Congenital pancreatic cyst 0 trials
- Follicular cholangitis and pancreatitis 0 trials
- Lymphoepithelial cyst of the pancreas 0 trials
- Pancreatic mucinous ductal ectasia 0 trials
- Pancreatic steatorrhea 0 trials
- Pancreatic triacylglycerol lipase deficiency 0 trials Sub-types →
-
Liver disorder 323 trials · 3,604 incl. sub-types
32 sub-types
- Liver and intrahepatic bile duct neoplasm 77 trials · 1,743 incl. sub-types Sub-types →
- Hepatitis 50 trials · 731 incl. sub-types Sub-types →
- Fatty liver disease 154 trials · 616 incl. sub-types Sub-types →
- Cirrhosis of liver 519 trials · 597 incl. sub-types Sub-types →
- Liver failure 71 trials · 197 incl. sub-types Sub-types →
- Hepatic vascular disorder 1 trial · 116 incl. sub-types Sub-types →
- Fibrotic liver disease 96 trials
- Alcoholic liver disease 44 trials · 85 incl. sub-types Sub-types →
- Drug-induced liver injury 21 trials · 23 incl. sub-types Sub-types →
- Hepatic porphyria 4 trials · 23 incl. sub-types Sub-types →
- Transient familial neonatal hyperbilirubinemia 18 trials
- Familial intrahepatic cholestasis 1 trial · 17 incl. sub-types Sub-types →
- Hepatorenal syndrome 13 trials
- Bile duct cyst 10 trials
- Liver abscess (disease) 4 trials
- Autosomal dominant polycystic liver disease 3 trials Sub-types →
- Cystic fibrosis-related liver disease 3 trials
- Intestinal failure–associated liver disease 3 trials
- Nodular regenerative hyperplasia of the liver 3 trials
- Glycogen storage disease due to liver phosphorylase kinase deficiency 0 trials · 2 incl. sub-types Sub-types →
- Aagenaes syndrome 1 trial
- Early-onset familial noncirrhotic portal hypertension 0 trials
- Hepatoportal sclerosis 0 trials
- Hepatopulmonary syndrome 0 trials
- Hyperbiliverdinemia 0 trials
- Idiopathic copper-associated cirrhosis 0 trials
- Liver disease, severe congenital 0 trials
- Membranous obstruction of inferior vena cava 0 trials
- Perinatal jaundice due to hepatocellular damage 0 trials
- Polycystic echinococcosis 0 trials
- Primitive portal vein thrombosis 0 trials
- Transient infantile hypertriglyceridemia and hepatosteatosis 0 trials
-
Endocrine gland neoplasm 8 trials · 3,332 incl. sub-types
14 sub-types
- Malignant endocrine neoplasm 17 trials · 2,924 incl. sub-types Sub-types →
- Liver and intrahepatic bile duct neoplasm 77 trials · 1,743 incl. sub-types Sub-types →
- Neuroendocrine neoplasm 181 trials · 985 incl. sub-types Sub-types →
- Thyroid tumor 36 trials · 366 incl. sub-types Sub-types →
- Thymus neoplasm 5 trials · 240 incl. sub-types Sub-types →
- Adrenal gland neoplasm 13 trials · 151 incl. sub-types Sub-types →
- Pituitary tumor 23 trials · 83 incl. sub-types Sub-types →
- Benign endocrine neoplasm 0 trials · 60 incl. sub-types Sub-types →
- Tumor of parathyroid gland 3 trials · 46 incl. sub-types Sub-types →
- Functioning endocrine neoplasm 0 trials · 38 incl. sub-types Sub-types →
- Pineal body neoplasm 4 trials · 22 incl. sub-types Sub-types →
- Non-functioning endocrine neoplasm 0 trials · 16 incl. sub-types Sub-types →
- Granulosa cell tumor 2 trials · 6 incl. sub-types Sub-types →
- Familial tumoral calcinosis 1 trial Sub-types →
-
Gonadal disorder 3 trials · 1,635 incl. sub-types
6 sub-types
- Ovarian disorder 10 trials · 1,388 incl. sub-types Sub-types →
- Hypogonadism 47 trials · 163 incl. sub-types Sub-types →
- Testicular disorder 2 trials · 111 incl. sub-types Sub-types →
- Disorder of sexual differentiation 9 trials · 53 incl. sub-types Sub-types →
- Precocious puberty 18 trials · 19 incl. sub-types Sub-types →
- Gonadoblastoma 0 trials Sub-types →
-
Autoimmune disorder of endocrine system 1 trial · 925 incl. sub-types
13 sub-types
- Type 1 diabetes mellitus 815 trials · 816 incl. sub-types Sub-types →
- Autoimmune thyroid disease 8 trials · 62 incl. sub-types Sub-types →
- Autoimmune hepatitis 30 trials · 31 incl. sub-types Sub-types →
- Autoimmune polyendocrinopathy 3 trials · 11 incl. sub-types Sub-types →
- Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome 10 trials
- Autoimmune hypoparathyroidism 0 trials · 8 incl. sub-types Sub-types →
- Autoimmune pancreatitis 3 trials Sub-types →
- Autoimmune primary ovarian failure 1 trial
- IgG4-related sclerosing cholangitis 0 trials
- Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome 0 trials
- Autoimmune oophoritis 0 trials
- Insulin autoimmune syndrome 0 trials
- Primary hypophysitis 0 trials Sub-types →
-
Thyroid gland disorder 96 trials · 538 incl. sub-types
12 sub-types
- Thyroid tumor 36 trials · 366 incl. sub-types Sub-types →
- Goiter 12 trials · 102 incl. sub-types Sub-types →
- Hyperthyroidism 27 trials · 70 incl. sub-types Sub-types →
- Thyroiditis 1 trial · 62 incl. sub-types Sub-types →
- Hypothyroidism 48 trials · 60 incl. sub-types Sub-types →
- Inherited thyroid metabolism disease 0 trials · 8 incl. sub-types Sub-types →
- C-cell hyperplasia 0 trials
- Atrophy of thyroid 0 trials
- Euthyroid sick syndrome 0 trials
- Hyperthyroxinemia 0 trials Sub-types →
- Thyrocalcitonin secretion disease 0 trials
- Thyroid malformation 0 trials
-
Adrenal gland disorder 9 trials · 352 incl. sub-types
18 sub-types
- Adrenal cortex disorder 0 trials · 185 incl. sub-types Sub-types →
- Adrenal gland neoplasm 13 trials · 151 incl. sub-types Sub-types →
- Adrenogenital syndrome 0 trials · 41 incl. sub-types Sub-types →
- Endogenous Cushing syndrome 3 trials · 38 incl. sub-types Sub-types →
- Pituitary dwarfism 38 trials Sub-types →
- Adrenoleukodystrophy 19 trials · 20 incl. sub-types Sub-types →
- Ectopic ACTH secretion syndrome 15 trials
- Autoimmune polyendocrine syndrome type 1 8 trials
- Primary pigmented nodular adrenocortical disease 2 trials Sub-types →
- Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency 1 trial
- Apparent mineralocorticoid excess 1 trial
- Hypoaldosteronism disease 1 trial Sub-types →
- Adrenal medullary hyperplasia 0 trials
- Adrenomyodystrophy 0 trials
- Corticosteroid-binding globulin deficiency 0 trials
- Isolated micronodular adrenocortical disease 0 trials
- Medulloadrenal hyperfunction 0 trials
- Pseudoleprechaunism syndrome, Patterson type 0 trials
-
Thymus gland disorder 1 trial · 240 incl. sub-types
3 sub-types
- Thymus neoplasm 5 trials · 240 incl. sub-types Sub-types →
- Ectopic thymus 0 trials
- Thymic dysplasia 0 trials
-
Polycystic ovary syndrome 200 trials
-
Hereditary endocrine growth disease 26 trials · 195 incl. sub-types
8 sub-types
- Non-acquired pituitary hormone deficiency 0 trials · 84 incl. sub-types Sub-types →
- Inherited primary ovarian failure 2 trials · 47 incl. sub-types Sub-types →
- Congenital adrenal hyperplasia 36 trials · 38 incl. sub-types Sub-types →
- Growth hormone insensitivity syndrome 0 trials · 6 incl. sub-types Sub-types →
- Permanent congenital hypothyroidism 1 trial · 3 incl. sub-types Sub-types →
- Zerres Rietschel Majewski syndrome 0 trials
- Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome 0 trials
- Microdontia hypodontia short stature 0 trials
-
Pituitary gland disorder 18 trials · 175 incl. sub-types
9 sub-types
- Pituitary tumor 23 trials · 83 incl. sub-types Sub-types →
- Anterior pituitary gland disorder 1 trial · 60 incl. sub-types Sub-types →
- Hypopituitarism 5 trials · 46 incl. sub-types Sub-types →
- Neurohypophyseal diabetes insipidus 9 trials
- Inappropriate ADH syndrome 5 trials
- Hypophysitis 2 trials Sub-types →
- Necrosis of pituitary 0 trials · 1 incl. sub-types Sub-types →
- Empty sella syndrome 0 trials
- Pituitary hypoplasia 0 trials
-
Non-neoplastic bile duct disorder 0 trials · 172 incl. sub-types
5 sub-types
- Cholangitis 17 trials · 139 incl. sub-types Sub-types →
- Biliary atresia 24 trials Sub-types →
- Obstructive jaundice 11 trials
- Caroli disease 1 trial
- Extrahepatic cholestasis 0 trials Sub-types →
-
Parathyroid gland disorder 14 trials · 164 incl. sub-types
4 sub-types
- Hyperparathyroidism 8 trials · 89 incl. sub-types Sub-types →
- Hypoparathyroidism 46 trials · 66 incl. sub-types Sub-types →
- Tumor of parathyroid gland 3 trials · 46 incl. sub-types Sub-types →
- Parathyroid hyperplasia 0 trials
-
Beta thalassemia 73 trials · 99 incl. sub-types
3 sub-types
- Beta-thalassemia HBB/LCRB 2 trials · 57 incl. sub-types Sub-types →
- Dominant beta-thalassemia 0 trials
- Thalassemia, beta+, silent allele 0 trials
-
Pituitary deficiency 0 trials · 96 incl. sub-types
5 sub-types
- Non-acquired pituitary hormone deficiency 0 trials · 84 incl. sub-types Sub-types →
- Central diabetes insipidus 5 trials · 12 incl. sub-types Sub-types →
- Acquired pituitary hormone deficiency 0 trials · 1 incl. sub-types Sub-types →
- Pituitary deficiency due to Rathke's pouch cysts 0 trials
- Pituitary deficiency due to empty sella turcica syndrome 0 trials
-
Polyendocrinopathy 0 trials · 81 incl. sub-types
7 sub-types
- Multiple polyglandular tumor 0 trials · 62 incl. sub-types Sub-types →
- Autoimmune polyendocrinopathy 3 trials · 11 incl. sub-types Sub-types →
- Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome 10 trials
- Bangstad syndrome 0 trials
- Autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome 0 trials
- Neuroectodermal-endocrine syndrome 0 trials
- Retinohepatoendocrinologic syndrome 0 trials
-
Neuroendocrine disorder 0 trials · 42 incl. sub-types
4 sub-types
- Pineal body neoplasm 4 trials · 22 incl. sub-types Sub-types →
- Central diabetes insipidus 5 trials · 12 incl. sub-types Sub-types →
- Cyclic vomiting syndrome 8 trials
- Posterior pituitary gland neoplasm 0 trials Sub-types →
-
Hyperinsulinemic hypoglycemia 2 trials · 14 incl. sub-types
5 sub-types
- Familial hyperinsulinism 9 trials · 12 incl. sub-types Sub-types →
- Hyperinsulinemic hypoglycemia, familial, 1 1 trial Sub-types →
- Hyperinsulinemic hypoglycemia with polycystic kidney disease 0 trials
- Hyperinsulinemic hypoglycemia, familial, 8 0 trials
- Insulin autoimmune syndrome 0 trials
-
Parneoplastic endocrine syndrome 0 trials · 11 incl. sub-types
2 sub-types
- POEMS syndrome 8 trials
- Oncogenic osteomalacia 3 trials
-
Inherited obesity 8 trials · 9 incl. sub-types
7 sub-types
- Obesity due to pro-opiomelanocortin deficiency 2 trials
- Obesity due to congenital leptin deficiency 1 trial
- Obesity due to leptin receptor gene deficiency 1 trial
- Obesity due to prohormone convertase I deficiency 1 trial
- Obesity due to CEP19 deficiency 0 trials
- Obesity due to SIM1 deficiency 0 trials
- Obesity due to melanocortin 4 receptor deficiency 0 trials
-
Acquired hypothalamic obesity 7 trials
-
Disorder of GNAS inactivation 0 trials · 7 incl. sub-types
5 sub-types
- Pseudohypoparathyroidism type 1A 7 trials
- Pseudopseudohypoparathyroidism 2 trials
- Progressive osseous heteroplasia 0 trials
- Pseudohypoparathyroidism type 1B 0 trials
- Pseudohypoparathyroidism type 1C 0 trials
-
Disorders of vitamin D metabolism 0 trials · 3 incl. sub-types
1 sub-type
- Hypocalcemic rickets 0 trials · 3 incl. sub-types Sub-types →
-
NKX2-1 related choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction 0 trials · 1 incl. sub-types
3 sub-types
- Thyroid cancer, nonmedullary, 1 1 trial
- Brain-lung-thyroid syndrome 0 trials
- Hereditary progressive chorea without dementia 0 trials
-
Familial hypocalciuric hypercalcemia 0 trials · 1 incl. sub-types
3 sub-types
-
17,20-lyase deficiency, isolated 0 trials
-
Bamforth-Lazarus syndrome 0 trials
-
Leydig cell hypoplasia 0 trials
2 sub-types
-
Wolfram-like syndrome 0 trials
-
Campomelic dysplasia 0 trials
-
Diencephalic syndrome 0 trials
-
Duplication of the pituitary gland 0 trials
-
Endocrine tuberculosis 0 trials
1 sub-type
- Hepatic tuberculosis 0 trials
-
Estrogen resistance syndrome 0 trials
-
Genito-palato-cardiac syndrome 0 trials
-
Neonatal iodine exposure 0 trials
-
Thyroid hormone metabolism, abnormal 0 trials
3 sub-types
- Thyroid hormone metabolism, abnormal 1 0 trials
- Thyroid hormone metabolism, abnormal, 2 0 trials
- Thyroid hormone metabolism, abnormal, 3 0 trials
Most studied deeper sub-types
Showing the 400 most recently updated of 3178 trials in this tab.
-
On-the-Spot hep c care at methadone clinics boosts cure rates
Cure CompletedThis study tested whether offering hepatitis C (HCV) treatment right at methadone clinics helps more people get cured compared to sending them to outside specialists. Over 600 adults on opioid addiction therapy took part across 13 clinics in Ukraine. Some clinics provided simplif…
Sponsor: Ukrainian Institute on Public Health Policy • Aim: Cure
Last updated Sep 18, 2026 00:00 UTC
-
Own bone marrow cells aimed at restarting ovaries
Cure CompletedResearchers are testing whether injecting a woman's own bone marrow cells into her ovaries can restore ovarian function in premature ovarian insufficiency, a condition where the ovaries stop working before age 40. Ten women with the diagnosis will receive the treatment, which inv…
Sponsor: abdulmajeed hammadi • Aim: Cure
Last updated Sep 16, 2026 00:00 UTC
-
Can an 8-Week pill regimen cure hepatitis c?
Cure CompletedThis trial tests whether an 8-week course of the combination pill elbasvir/grazoprevir can cure chronic hepatitis C in people with genotype 1b who have not been treated before and have mild liver fibrosis. The main goal is to see if the virus stays undetectable 12 weeks after fin…
Phase 3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Cure
Last updated Aug 26, 2026 00:00 UTC
-
Can one shot replace six? a new vaccine aims to protect infants from six diseases at once
Vaccine CompletedResearchers are testing a new vaccine called LBVD that combines protection against diphtheria, tetanus, whooping cough, hepatitis B, polio, and Hib into a single injection. The study will enroll healthy infants aged 6 to 8 weeks, who will receive three doses at 6, 10, and 14 week…
Phase 2/3 • Sponsor: LG Chem • Aim: Vaccine
Last updated Sep 05, 2026 00:00 UTC
-
Gut bacteria in a capsule: a new attempt to calm a brain complication of cirrhosis
Disease control CompletedResearchers test whether fecal microbiota transplantation delivered by oral capsules can help cirrhosis patients whose hepatic encephalopathy no longer responds to standard lactulose and rifaximin. The trial enrolls 33 adults with cirrhosis and persistent or recurrent hepatic enc…
Phase 1 • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Double immunotherapy attack shows promise in tough lung cancer
Disease control CompletedThis Phase 3 study tests whether adding tiragolumab (an experimental immunotherapy) to the standard combination of atezolizumab plus chemotherapy can help people with untreated, widespread small cell lung cancer live longer without their disease worsening. About 123 participants …
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New pill takes aim at blood sugar in diabetes
Disease control CompletedResearchers are testing an experimental oral drug called MBX-2982 in adults with type 2 diabetes. The trial compares three daily doses of MBX-2982 against a placebo and sitagliptin, a standard diabetes drug, over four weeks. Participants are treatment-naive or taking a single ora…
Phase 2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a probiotic blend melt away liver fat?
Disease control CompletedResearchers are testing whether a synbiotic supplement called SLP07 can reduce liver fat in people with metabolic dysfunction-associated fatty liver disease. The supplement combines probiotic bacteria, omega 3, and vitamin E. The trial enrolls 54 adults aged 50 and older who have…
Sponsor: GenieBiome Limited • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Smart pen cap could help tame blood sugar in type 1 diabetes
Disease control CompletedThis study tested a smart cap that attaches to insulin pens to help people with type 1 diabetes track their injections and glucose data. 42 adults used the device or a blinded version for comparison. The goal was to see if it reduces time spent with high blood sugar and improves …
Sponsor: Fernando Sebastián Valles • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a health coach in your patient portal help you lose weight?
Disease control CompletedResearchers are testing whether a 24-month weight-loss program delivered by trained health coaches through an electronic medical record patient portal can help Black adults with obesity and type 2 diabetes or prediabetes. The study enrolls 352 people aged 40 to 70 in Louisiana pr…
Sponsor: Pennington Biomedical Research Center • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Common antibiotic may boost diabetes control
Disease control CompletedResearchers test whether adding doxycycline to sitagliptin helps control blood sugar and heart health in adults over 40 with newly diagnosed type 2 diabetes. Participants receive both drugs, and the team tracks changes in fasting blood sugar and HbA1c. The trial also measures hea…
Phase 1/2 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can an oral drug slow a rare thymus cancer?
Disease control CompletedResearchers are testing whether lucitanib, an oral drug, can slow the growth of advanced thymic carcinoma that has worsened after at least one round of chemotherapy. The trial enrolls adults with recurrent or metastatic thymic carcinoma. In one part, participants receive lucitani…
Phase 2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Elderly cancer patients may benefit from geriatric support
Disease control CompletedThis study looked at whether a special care plan led by a geriatrician and a nurse could improve survival and quality of life for older adults (70+) with advanced cancer. 792 patients with breast, colorectal, lung, prostate, bladder, ovarian cancer, or lymphoma took part. The app…
Sponsor: Institut Bergonié • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
App-Based reminders could revolutionize diabetes Self-Care for seniors
Disease control CompletedThis study tests a mobile app that sends personalized reminders to help older adults with diabetes manage their blood sugar, diet, and medications. 184 participants will either use the app or receive standard nurse consultations. The goal is to see if the app can improve diabetes…
Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a common supplement ease arthritis pain and lower blood sugar?
Disease control CompletedThis study tests whether acetyl L-carnitine, a dietary supplement, can help reduce pain, inflammation, and improve blood sugar control in obese, diabetic, postmenopausal women with osteoarthritis. One hundred women will take either the supplement or a placebo for 12 weeks, alongs…
Sponsor: Khyber Medical University Peshawar • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Can a Plant-Based diet program help patients lose weight and improve heart health?
Disease control CompletedResearchers are testing a 12-week low-fat, plant-based diet program delivered in a doctor's office. The program encourages whole grains, vegetables, legumes, and fruits, with no animal products or added oils, and no calorie counting. The study measures changes in weight, blood pr…
Sponsor: Physicians Committee for Responsible Medicine • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug shows promise for rare liver disease in Late-Stage trial
Disease control CompletedThis study tested a drug called saroglitazar magnesium in 196 adults with primary biliary cholangitis (PBC), a chronic liver disease. Participants either took the drug or a placebo to see if it improved liver function markers. The goal was to lower certain liver enzymes and bilir…
Phase 2/3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Could 'Peacekeeper' cells free liver transplant patients from lifelong drugs?
Disease control CompletedThis early-phase trial tests whether infusing specially grown donor-specific regulatory T cells (Tregs) can allow liver transplant recipients to safely reduce or stop their anti-rejection medications. Nine participants will receive a single dose of these cells and be monitored fo…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can one workout a week melt liver fat?
Disease control CompletedResearchers are testing whether a low-frequency high-intensity interval training (HIIT) program can reduce body fat and liver fat in adults with central obesity and non-alcoholic fatty liver disease. The trial enrolls 160 adults aged 18 to 60 who have a BMI of at least 25 and a l…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Can a glucose sensor and family coaching tame type 1 diabetes in toddlers?
Disease control CompletedResearchers are testing whether continuous glucose monitoring, alone or combined with a family behavioral program, helps children under 8 with type 1 diabetes keep their blood sugar in a healthy range. The trial compares these approaches to standard home blood glucose monitoring.…
Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Diabetes snack break: golden rice cookies take on bad cholesterol
Disease control CompletedThis study tests whether a cookie made from Golden Rice and red betel leaf can improve cholesterol and triglyceride levels in adults with type 2 diabetes. Over 28 days, 102 participants will eat the cookies daily, and their blood fat levels will be measured before and after. The …
Sponsor: Hasanuddin University • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New cocktail of three drugs tested for tough bladder cancers
Disease control CompletedThis early-phase trial tested a combination of two chemotherapy drugs (gemcitabine and carboplatin) plus lenalidomide, a drug that blocks blood vessel growth in tumors, in 18 adults with advanced solid tumors, especially urothelial (bladder) cancer. The main goal was to find the …
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New drug combo aims to shrink tough head and neck tumors
Disease control CompletedThis study tests a mix of antibodies that help the immune system fight cancer, block tumor growth signals, and cut off the tumor's blood supply. It is for adults with head and neck cancer that did not respond to prior treatment or has no standard options. Participants receive inf…
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Food delivery program helps rural diabetes patients control blood sugar
Disease control CompletedThis study looked at whether delivering healthy food to the homes of rural adults with type 2 diabetes and food insecurity could improve their blood sugar control and diet. Over 400 participants either received standard care alone or standard care plus free healthy food deliverie…
Sponsor: University of Arkansas • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Smart pillbox aims to keep patients on track
Disease control CompletedResearchers test whether a connected pillbox with pre-filled trays and automated text or phone reminders helps people with type 2 diabetes, high blood pressure, or high cholesterol take their medications as prescribed. The study enrolls about 50 adults who have struggled to stay …
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a Pharmacist's guidance with a glucose monitor improve diabetes control?
Disease control CompletedThis pilot study tests whether having a pharmacist oversee continuous glucose monitoring (using a FreeStyle Libre device) can improve blood sugar control and health behaviors in people with type 2 diabetes. Forty participants will use the monitor for 12 weeks, and their results w…
Sponsor: University of South Florida • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New diabetes drug MK-1403 enters human testing
Disease control CompletedThis early-stage study tests an experimental drug called MK-1403 in people with type 2 diabetes. The main goals are to check if the drug is safe and tolerable, and to see how it behaves in the body. Researchers will also measure its effect on a marker of inflammation (hsCRP). Abo…
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New shot aims to cure chronic hepatitis b – early trial underway
Disease control CompletedThis study tests a new drug called AHB-137 in 86 adults with chronic hepatitis B who are already on standard antiviral pills. The goal is to see if AHB-137 can clear the hepatitis B surface antigen from the blood, which would mean the virus is under control and patients might be …
Phase 2 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Can a social media platform help manage gestational diabetes?
Disease control CompletedThis pilot trial tests whether a social media platform can provide continuous dietary and lifestyle support for women with gestational diabetes. Forty pregnant women diagnosed with gestational diabetes receive either usual care from a diabetes nurse and dietitian, or usual care p…
Sponsor: KK Women's and Children's Hospital • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Exercise and diet combo shows promise for diabetes control
Disease control CompletedThis study looks at how different exercise programs (moderate or high-intensity) and a diet plan affect appetite, blood sugar, and body fat in people with type 2 diabetes. About 146 adults will take part in a 12-week program. The goal is to find the best combination to improve he…
Sponsor: University of Cadiz • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New diabetes pill takes on semaglutide in Head-to-Head trial
Disease control CompletedThis phase 3 study tested a new once-daily pill called orforglipron against an existing oral semaglutide in nearly 1,700 adults with type 2 diabetes whose blood sugar was not well controlled on metformin. The main goal was to see how well orforglipron lowers blood sugar levels ov…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New pill aims to tackle obesity and diabetes by calming inflammation
Disease control CompletedThis study tests an experimental drug called NT-0796 in 176 obese adults, some with type 2 diabetes. Participants take the drug or a placebo alongside a reduced-calorie diet and increased physical activity for 6 months. The goal is to see if the drug helps with weight loss and re…
Phase 2 • Sponsor: Rezera (formerly NodThera Limited) • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Three blockbuster Weight-Loss drugs go Head-to-Head in diabetic and Non-Diabetic adults
Disease control CompletedResearchers compare three weekly GLP-1 receptor agonists, dulaglutide, semaglutide, and tirzepatide, in 159 obese adults, 84 with diabetes and 75 without. Participants receive one of the drugs for 24 weeks. The trial measures changes in body weight, BMI, blood sugar, cholesterol,…
Phase 3 • Sponsor: Zagazig University • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Double attack on liver tumors: radiotherapy plus chemoembolization
Disease control CompletedResearchers test whether adding high-dose radiotherapy to standard chemoembolization slows tumor growth better than chemoembolization alone in adults with hepatocellular carcinoma. Participants have liver tumors up to 9 cm that cannot be removed by surgery or treated with percuta…
Phase 2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can continuous glucose monitors safely tighten hospital blood sugar control?
Disease control CompletedResearchers test whether continuous glucose monitors (CGM) can help hospitalized adults with type 2 diabetes reach a tighter average blood sugar target of 90 to 130 mg/dL without causing dangerous low blood sugar. Participants are randomly assigned to standard care (target 140 to…
Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a common statin tame cirrhosis complications?
Disease control CompletedResearchers are testing whether atorvastatin, a widely used cholesterol drug, can reduce complications in people with decompensated liver cirrhosis. The trial enrolls 100 adults aged 18 to 75 who have had at least one serious cirrhosis complication, such as ascites, jaundice, or …
Phase 2/3 • Sponsor: Tanta University • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Could a spoonful of yoghurt replace awkward tongue dosing for a lifesaving steroid?
Disease control CompletedResearchers are testing whether hydrocortisone granules (Infacort) mixed with yoghurt or soft food get into the bloodstream as well as dry granules placed on the back of the tongue. The study enrolls 19 healthy adult men whose natural cortisol is temporarily suppressed with dexam…
Phase 1 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Texts and doctor visits may help diabetes patients stick to meds
Disease control CompletedThis study tests whether combining a shared decision-making checklist during doctor visits with mobile text reminders helps people with type 2 diabetes take their medications as prescribed. About 378 patients from community health centers in Michigan are taking part. The goal is …
Sponsor: Michigan State University • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a math model tune insulin pumps better than standard care?
Disease control CompletedResearchers at Nantes University Hospital are testing a computer model that describes how glucose and insulin interact in people with type 1 diabetes. The model aims to help doctors choose insulin pump settings, including basal rate, insulin sensitivity, and carbohydrate ratios. …
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Granule vs tablet: can a new hydrocortisone form match the standard?
Disease control CompletedResearchers are testing whether a granule form of hydrocortisone called Infacort is absorbed into the body as well as standard hydrocortisone tablets (Cortef). The study enrolls healthy adults aged 18 to 55 and gives each participant both forms in a random order, once while fasti…
Phase 1 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a pill replace shots for low testosterone?
Disease control CompletedResearchers are testing an oral form of native testosterone called DITEST in men with primary or secondary hypogonadism. The trial measures how much testosterone reaches the blood after a single dose, both with and without food, and compares it to an existing oral testosterone tr…
Phase 1 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a modified hydrocortisone mimic the Body's natural cortisol rhythm?
Disease control CompletedResearchers are testing Chronocort, a modified-release form of hydrocortisone, against standard immediate-release hydrocortisone in 30 healthy male volunteers. The study measures how the drug moves through the body, including how fast it reaches peak levels and how long it stays …
Phase 1 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Two hydrocortisone pills go Head-to-Head in adrenal insufficiency trial
Disease control CompletedResearchers are comparing two modified-release hydrocortisone pills, Chronocort and Plenadren, in adults with primary adrenal insufficiency, a condition where the adrenal glands do not make enough cortisol. The study is a phase 2, double-blind, crossover trial: participants recei…
Phase 2 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Radioactive antibody combo targets thyroid cancer
Disease control CompletedResearchers are testing a two-step radioimmunotherapy for people with medullary thyroid cancer that has come back. Participants receive a bispecific antibody followed by a radioactive peptide. The goal is to see if this targeted radiation can shrink tumors and how safe it is.
Phase 2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New combo immunotherapy drug enters human trials for 18 cancers
Disease control CompletedThis early-phase trial tests a new drug called AI-061, which combines two immune-boosting antibodies (anti-PD-1 and anti-CTLA-4) into one treatment. The study will enroll 18 adults with advanced solid tumors that have spread or cannot be removed. The main goals are to find a safe…
Phase 1 • Sponsor: OncoC4, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can an ancient herbal brew tame the deadliest pancreatitis?
Disease control CompletedSevere acute pancreatitis causes the pancreas to swell dangerously, and pressure building inside the abdomen can lead to organ failure. Researchers at a Shanghai hospital are testing whether adding Da-Cheng-Qi Decoction, a classic Chinese herbal formula, to standard Western treat…
Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug cocktail aims to outsmart resistant ovarian cancer
Disease control CompletedThis Phase 2 trial tests two experimental drug combinations in 63 women with a specific type of ovarian cancer (BRCA-mutant or HRD-positive) that has worsened after prior PARP inhibitor treatment. Participants receive either tuvusertib plus niraparib or tuvusertib plus larteserti…
Phase 2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a Timed-Release hydrocortisone pill match the Body's overnight hormone rhythm?
Disease control CompletedResearchers are testing several modified, timed-release versions of hydrocortisone, a hormone drug, in healthy male volunteers. The study has two parts: one compares how six different formulations move through the body after a single nighttime dose, and the other checks whether t…
Phase 1 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Can a Modified-Release hydrocortisone mimic the Body's natural rhythm?
Disease control CompletedResearchers are testing how the body absorbs Chronocort, a modified-release hydrocortisone, compared with Cortef, a standard immediate-release hydrocortisone tablet. The study enrolls healthy adult men whose natural cortisol production is temporarily suppressed with dexamethasone…
Phase 1 • Sponsor: Neurocrine UK Limited • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat cancers
Disease control CompletedThis early-stage trial is testing a new drug called tuvusertib, given together with either lartesertib or avelumab, in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see how the body pr…
Phase 1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New Long-Acting shot takes aim at Acromegaly's hormone overload
Disease control CompletedAcromegaly is a rare condition where the pituitary gland makes too much growth hormone, causing bones and tissues to enlarge. Researchers are testing a long-acting octreotide injection called SYHX2008 in 78 adults with active acromegaly. Participants receive either the new inject…
Phase 2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Magnets in the gut: a new way to treat obesity and diabetes?
Disease control CompletedThis early study is testing a new magnetic device that creates a shortcut in the digestive system to help people with obesity and type 2 diabetes lose weight and control blood sugar. Ten adults aged 18-65 with a BMI between 30 and 35 will have the device placed using a scope, wit…
Sponsor: GT Metabolic Solutions, Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Magnetic bypass: a new tool to fight obesity and diabetes?
Disease control CompletedThis study tests a new magnetic system (MagDI) that creates a connection between two parts of the small intestine to help with weight loss and blood sugar control. It involves 25 adults with obesity and type 2 diabetes. The goal is to see if the device is safe, works as intended,…
Sponsor: GT Metabolic Solutions, Inc. • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Could a diabetes drug protect kidneys in obesity? new trial investigates
Disease control CompletedThis Phase 2 trial tests whether tirzepatide, a drug already used for diabetes and weight loss, can improve kidney health in 140 people with obesity and chronic kidney disease (with or without type 2 diabetes). Researchers will use MRI scans to measure changes in kidney fat and b…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Filtering blood to tame Pancreatitis's cytokine storm
Disease control CompletedResearchers test a blood purification device called Efferon CT combined with high-volume hemofiltration in adults with acute pancreatitis. The goal is to see if removing inflammatory molecules from the blood reduces organ dysfunction and improves recovery. The trial enrolls 28 pa…
Sponsor: Efferon JSC • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can a gout drug stop cirrhosis from getting worse?
Disease control CompletedResearchers are testing whether allopurinol can interfere with the processes that lead to hepatic decompensation, a serious complication of cirrhosis. The trial enrolls 100 adults aged 18 to 75 with cirrhosis. Participants receive either allopurinol tablets or a placebo, and rese…
Phase 1/2 • Sponsor: Tanta University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Higher radiation dose vs standard: which fights small cell lung cancer better?
Disease control CompletedResearchers are comparing two doses of chest radiation therapy, 45 Gy and 70 Gy, in people with limited-stage small cell lung cancer. All participants also receive chemotherapy with cisplatin or carboplatin plus etoposide. The trial measures overall survival to see whether the hi…
Phase 3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can metformin plus coaching reshape PCOS health?
Disease control CompletedPolycystic ovary syndrome (PCOS) often comes with insulin resistance, cholesterol problems, and other metabolic issues. Researchers are testing whether metformin, a common diabetes drug, changes metabolic, vitamin B12, iron, and blood measures in women with PCOS, and whether addi…
Phase 4 • Sponsor: Jerash Private University • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New drug combo takes on tough cancers in early trial
Disease control CompletedThis early-phase trial tested a new drug called vilastobart, alone or with another drug (atezolizumab), in 125 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the right dose. Researchers also looke…
Phase 1/2 • Sponsor: Xilio Development, Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New pump insulin could speed up blood sugar control for type 1 diabetes
Disease control CompletedThis completed Phase 1 study tested a new fast-acting insulin called NNC0471-0119 in 43 adults with type 1 diabetes who use an insulin pump. The goal was to see how quickly the insulin enters the bloodstream, how long it works, and how safe it is compared to a standard insulin (i…
Phase 1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can adding a second diabetes drug do more than lower blood sugar?
Disease control CompletedResearchers are testing whether adding an SGLT2 inhibitor to the usual treatment for type 2 diabetes improves blood sugar control and other metabolic measures. The trial enrolls about 482 adults with type 2 diabetes who are not already taking these drugs. Participants will be com…
Phase 4 • Sponsor: Assiut University • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Can adding estrogen to letrozole boost fertility in PCOS?
Disease control CompletedThis study will test whether adding estradiol valerate to letrozole improves the uterine lining in 60 women with PCOS compared to letrozole alone. Participants will be randomly assigned to one of two groups and monitored via ultrasound. The goal is to see if the combination leads…
Sponsor: CMH Kharian Medical College • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Simple alerts may keep At-Risk moms healthy after birth
Disease control CompletedThis study tests whether giving doctors a reminder and providing patients with a one-page handout can help women who had gestational diabetes or high blood pressure during pregnancy get a primary care visit within six months of delivery. The goal is to prevent future diabetes and…
Phase 3 • Sponsor: Northwestern University • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New pill could tame rare hormone disorder
Disease control CompletedThis study tested a new oral drug called atumelnant in 38 adults with classic congenital adrenal hyperplasia, a genetic condition causing hormone imbalances. The drug works by blocking a hormone receptor to lower excess adrenal hormones. Researchers measured safety, side effects,…
Phase 2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Could zinc and a liver pill help newborns beat jaundice faster?
Disease control CompletedThis study tests whether giving oral zinc sulfate and ursodeoxycholic acid alongside standard light therapy can help clear jaundice faster in newborns. About 80 babies with non-hemolytic jaundice will receive one of two doses of zinc, or the liver drug UDCA, plus phototherapy. Th…
Phase 4 • Sponsor: Amira Adel Fouly • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Smartphone app aims to tame PCOS symptoms through diet and exercise
Disease control CompletedThis study tests whether a specially designed mobile app can help women with Polycystic Ovary Syndrome (PCOS) improve their eating and exercise habits. About 92 women will either use the app or receive a pamphlet with advice. The goal is to see if the app leads to better weight m…
Sponsor: Istanbul Medipol University Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New weekly shot shows promise for weight loss in type 2 diabetes
Disease control CompletedThis Phase 2 trial tests a once-weekly injection called petrelintide in 221 people with overweight or obesity and type 2 diabetes. Participants receive either petrelintide or a placebo for several weeks. The main goal is to see how much weight they lose and whether blood sugar im…
Phase 2 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New combo shot CagriSema shows promise for diabetes and weight loss
Disease control CompletedThis study tested a new investigational medicine called CagriSema, which combines two drugs (cagrilintide and semaglutide) in one weekly injection. It was given to 274 adults with type 2 diabetes who were already taking daily insulin, with or without metformin. The goal was to se…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Telehealth program aims to get HIV treatment to people who inject drugs faster
Disease control CompletedThis study tested two ways to offer HIV treatment, hepatitis C treatment, and substance use disorder medications to people who inject drugs. One group received a telehealth-enhanced program with on-demand services like mobile blood draws and counseling, while the other group got …
Sponsor: University of Miami • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New combo drug CagriSema takes on tirzepatide in diabetes showdown
Disease control CompletedThis study tests a new investigational medicine called CagriSema against an approved drug, tirzepatide, in people with type 2 diabetes whose blood sugar is not well controlled by current pills. About 1,023 adults will receive either CagriSema or tirzepatide once a week for up to …
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Experimental drug targets EGFR-Positive bile duct cancer after standard treatment fails
Disease control CompletedResearchers are testing an experimental drug called MRG003 in adults with biliary tract cancer that is EGFR-positive and cannot be removed by surgery or has spread. The trial enrolls people whose cancer worsened after at least one standard treatment. Everyone receives MRG003 by i…
Phase 2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Statin drug tested to stop liver cancer in cirrhosis patients
Disease control CompletedThis phase 2 trial tests whether simvastatin, a widely used cholesterol-lowering drug, can prevent liver cancer in 52 adults with liver cirrhosis. Participants take simvastatin and are monitored with blood tests and imaging to see if cancer-related markers change. The goal is to …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a Dual-Drug approach tackle fatty liver disease and diabetes together?
Disease control CompletedResearchers are testing whether lanifibranor, a drug for fatty liver disease, can improve blood sugar control in adults with NASH and type 2 diabetes. They are also studying whether combining lanifibranor with empagliflozin, a diabetes medication, works better than lanifibranor a…
Phase 2 • Sponsor: Inventiva Pharma • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for pancreatic cancer? early trial combines novel drug with chemo and immunotherapy
Disease control CompletedThis early-phase study tests a new drug called AB680, combined with immunotherapy (zimberelimab) and two chemotherapy drugs (nab-paclitaxel and gemcitabine), in people with advanced pancreatic cancer that has spread. The main goals are to check safety and find the right dose. Abo…
Phase 1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can sharing decisions with your doctor tame type 2 diabetes?
Disease control CompletedResearchers test whether shared decision making helps adults with type 2 diabetes who have poor blood sugar control. Participants are randomly assigned to receive either shared decision making sessions or routine health education. The trial measures changes in self-efficacy, heal…
Sponsor: Fooyin University • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Sugar-like supplement may boost fertility in PCOS women resistant to common drug
Disease control CompletedThis study looked at whether inositol, a natural supplement, can improve ovulation in women with polycystic ovary syndrome (PCOS) who did not respond to the fertility drug letrozole. 36 women aged 18-35 took part. The researchers compared inositol to metformin, another common tre…
Phase 2/3 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Can a new interferon tame hepatitis d?
Disease control CompletedThis phase 2 trial tests whether peginterferon lambda, an experimental interferon drug, can safely reduce hepatitis D virus levels in people with chronic infection. Participants receive one of two doses of the drug for 48 weeks, and researchers measure changes in viral load and l…
Phase 2 • Sponsor: EIT Pharma, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
A shot to skip the misery of thyroid hormone withdrawal before cancer treatment?
Disease control CompletedThis phase 3 trial tests whether giving recombinant human thyrotropin (rhTSH) injections before radioactive iodine can effectively destroy leftover thyroid tissue after surgery for differentiated thyroid cancer. Normally, patients must stop thyroid hormone medication to raise TSH…
Phase 3 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for tough lung cancer: LAGOON trial tests powerful drug combo
Disease control CompletedThis study tested two new treatments for people with small cell lung cancer that came back after initial chemotherapy. The experimental drugs, lurbinectedin alone or with irinotecan, were compared to standard treatments (topotecan or irinotecan). The goal was to see if the new op…
Phase 3 • Sponsor: PharmaMar • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a faster insulin improve blood sugar control in teens with type 1 diabetes?
Disease control CompletedThis completed trial tested whether a faster-acting insulin (Lyumjev) used with a special conversion factor in an automated insulin pump (Control-IQ) could improve blood sugar control in 11 adolescents with type 1 diabetes. Participants were randomly assigned to use Lyumjev with …
Sponsor: Mark D. DeBoer, MD, MSc., MCR • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a pill tame the relentless hunger of Prader-Willi syndrome?
Disease control CompletedThis phase 2 trial tests an oral drug called ARD-101 in adults with Prader-Willi syndrome, a genetic condition that causes an unrelenting feeling of hunger. Researchers give the drug twice daily for 28 days to see if it safely reduces hyperphagia, the intense drive to eat, using …
Phase 2 • Sponsor: Aardvark Therapeutics, Inc. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Intensive insulin strategy may ease diabetes drug burden
Disease control CompletedThis study tested whether a short period of intensive insulin therapy, followed by a combination of basal insulin, metformin, and vildagliptin, could help people with poorly controlled type 2 diabetes simplify their long-term treatment. The goal was to see if more participants co…
Phase 4 • Sponsor: Yanbing Li • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Home workouts may boost fitness in liver disease
Disease control CompletedThis trial tests whether 8 weeks of home-based exercise can improve physical fitness, muscle strength, and quality of life in adults with chronic liver disease. Participants are split into three groups: aerobic exercise, aerobic plus resistance exercise, or a control group receiv…
Sponsor: Hacettepe University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Natural vitamin e pill may delay liver transplant in cirrhosis patients
Disease control CompletedThis phase 2 trial tests whether a natural vitamin E supplement called tocotrienol can slow the worsening of end-stage liver disease. Seventy adults with stable but advanced liver disease (MELD score 8–17) will take either tocotrienol or a placebo twice daily for three years. The…
Phase 2 • Sponsor: Chandan Sen • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Electric field therapy combined with chemo shows promise for tough pancreatic cancer
Disease control CompletedThis pilot study tested a wearable device that delivers low-intensity electric fields (TTFields) together with immunotherapy (atezolizumab) and two chemotherapy drugs (gemcitabine and nab-paclitaxel) in 84 people with metastatic pancreatic cancer who had not received prior treatm…
Phase 2 • Sponsor: NovoCure Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New daily pill could help people with obesity and diabetes shed pounds
Disease control CompletedThis phase 3 study tested an experimental once-daily pill called orforglipron (LY3502970) against a placebo in 1613 adults who are overweight or have obesity and type 2 diabetes. The goal was to see if the drug helps with weight loss and improves blood sugar control. Participants…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Boosting thyroid cancer therapy: does rhTSH make radioactive iodine more effective?
Disease control CompletedThis phase 2 trial tests whether giving recombinant human thyroid stimulating hormone (rhTSH) before radioactive iodine can improve the destruction of leftover thyroid tissue after surgery in people with differentiated thyroid cancer. Participants receive either rhTSH injections …
Phase 2 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a triple therapy shrink pancreatic tumors enough for complete surgery?
Disease control CompletedThis phase II trial tests whether giving chemotherapy and proton beam radiation before surgery can help people with borderline-resectable pancreatic cancer. The goal is to shrink the tumor enough so that surgeons can remove it completely, with no cancer cells left at the edges. P…
Phase 2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New combo shot CagriSema takes on tirzepatide in diabetes showdown
Disease control CompletedThis study tested a new investigational drug called CagriSema against a currently available medicine, tirzepatide, in over 1,000 adults with type 2 diabetes. The goal was to see which works better at lowering blood sugar and body weight. Participants received weekly injections of…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
A smarter way to choose liver cancer treatment? a new model aims to match therapy to the patient.
Disease control CompletedThis study tests a decision model that aims to predict whether a person with unresectable hepatocellular carcinoma, a type of liver cancer, will benefit more from transarterial chemoembolization (TACE) alone or TACE combined with atezolizumab plus bevacizumab. Researchers will de…
Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Gene-Guided diabetes care shows promise in new trial
Disease control CompletedThis study tests whether choosing diabetes medications based on a person's genetic profile helps control blood sugar better than standard treatment. About 500 adults with type 2 diabetes that is not well controlled will be randomly assigned to either gene-guided or standard care.…
Phase 4 • Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Heartburn drug could ease painful sun sensitivity
Disease control CompletedThis Phase 2 trial tested whether oral cimetidine (Tagamet), a common heartburn drug, can reduce light sensitivity in people with erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP). These genetic conditions cause severe pain from sunlight exposure. The study en…
Phase 2 • Sponsor: Amy K. Dickey, M.D. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New radiation approach targets tough pancreatic tumors
Disease control CompletedThis study tests whether giving higher doses of radiation, guided by MRI, can help people with pancreatic cancer that cannot be removed by surgery. Participants must have already had several months of chemotherapy without the cancer spreading. The goal is to see if this approach …
Phase 2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Promising long-term results for rare liver disease drug in kids
Disease control CompletedThis study looked at the long-term safety and effectiveness of a drug called A4250 (odevixibat) in 116 children with progressive familial intrahepatic cholestasis (PFIC), a rare liver disease. The children took the drug for up to 72 weeks. The study measured changes in bile acid …
Phase 3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a new injection tackle obesity, diabetes, and liver disease?
Disease control CompletedThis early-stage trial tests an investigational drug called MWN105, given as an injection under the skin, in healthy Chinese volunteers aged 18 to 45. The study aims to check the drug's safety, how the body processes it, and whether it triggers an immune response. Researchers wil…
Phase 1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Herbal hope: new combo therapy targets advanced pancreatic cancer
Disease control CompletedThis study tested whether adding a Chinese herbal formula (QingyiHuaji) to standard chemotherapy helps people with stage IV pancreatic cancer live longer. About 305 adults with advanced pancreatic cancer were randomly assigned to receive either the herbal formula plus chemo or a …
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can when you eat change how a diabetes drug works?
Disease control CompletedThis trial tests an oral medication called MWN109 in Chinese adults with type 2 diabetes, overweight, or obesity. Researchers want to see if the amount of water taken with the pill and the timing of the next meal change how much drug enters the blood. The study also checks safety…
Phase 1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New daily pill could help control blood sugar in type 2 diabetes
Disease control CompletedThis study tested a once-daily pill called orforglipron in 559 adults with type 2 diabetes whose blood sugar was not well controlled by diet and exercise alone. The pill was compared to a placebo (a dummy pill) over about 54 weeks to see if it safely lowers blood sugar levels. Th…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Pumping iron for diabetes: effort matters more than you think?
Disease control CompletedThis study looks at whether the amount of effort you put into strength training can improve blood sugar control and mental health in people with type 2 diabetes. About 48 adults with type 2 diabetes will do resistance exercises at different effort levels. Researchers will track b…
Sponsor: University of New Mexico • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a Two-Drug combo tame Hard-to-Treat pancreatic cancer?
Disease control CompletedThis phase II trial tests whether combining niraparib and dostarlimab can control metastatic pancreatic cancer in people who carry BRCA1/2 or PALB2 gene mutations. Niraparib blocks enzymes that cancer cells need to grow, while dostarlimab helps the immune system attack the tumor.…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can one extra stitch in pancreatic surgery get patients eating again sooner?
Disease control CompletedThis trial tests whether adding a Braun anastomosis, an extra connection between two parts of the small intestine, during standard pancreatic surgery helps prevent delayed gastric emptying. Delayed gastric emptying is a common complication where the stomach is slow to empty food,…
Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New cocktail aims to outsmart pancreatic cancer
Disease control CompletedThis early-phase trial tests a combination of two immunotherapy drugs (nivolumab and ipilimumab), a vaccine targeting TGFβ-15, and targeted radiation for pancreatic cancer that has not responded to standard treatments. The goal is to see if this mix can safely boost the immune sy…
Phase 1 • Sponsor: Inna Chen, MD • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Mindfulness may curb diabetes risk in depressed teens
Disease control CompletedThis study tested whether a 6-week mindfulness program could help teens at risk for type 2 diabetes by reducing depression and insulin resistance. 120 teens aged 12-17 with overweight, a family history of diabetes, and elevated depression symptoms took part. They were randomly as…
Sponsor: Colorado State University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a crocosmia bulb compound tame type 2 diabetes?
Disease control CompletedThis early trial tests montbretin A, a compound extracted from crocosmia plant bulbs, in people with type 2 diabetes and in healthy volunteers. The main goal is to find a safe dose and see if it causes fewer stomach side effects than standard diabetes medications. Participants ta…
Phase 1 • Sponsor: Robert Petrella • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for type 1 diabetes: can common diabetes drugs improve blood sugar control?
Disease control CompletedThis study tests whether adding empagliflozin or semaglutide to insulin can improve blood sugar control in overweight or obese adults with type 1 diabetes. About 105 participants will take one of the two drugs or a placebo for 3 months. The goal is to see if these drugs help lowe…
Phase 2 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a new antibody help the immune system fight Hard-to-Treat tumors?
Disease control CompletedThis trial tests an experimental drug called SNS-101, which targets a protein called VISTA that may help tumors evade the immune system. Researchers give SNS-101 alone or with another immunotherapy, cemiplimab, to adults with advanced solid tumors that have not responded to stand…
Phase 1/2 • Sponsor: Sensei Biotherapeutics, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Blueberry powder tested as natural blood pressure aid
Disease control CompletedThis study tests whether eating wild blueberry powder every day can lower blood pressure and improve blood vessel health in middle-aged and older men and postmenopausal women with slightly high blood pressure. Researchers will measure artery function and stiffness over time. The …
Phase 1/2 • Sponsor: Colorado State University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Food as medicine: tailored meals show promise for diabetes and hunger
Disease control CompletedThis study tested whether providing medically tailored meals (10 ready-to-eat meals per week for 6 months) plus phone-based lifestyle coaching could improve blood sugar control in adults with type 2 diabetes who also face food insecurity. 215 participants were randomly assigned t…
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New pill shows promise for Diabetes-Related vision loss
Disease control CompletedThis study tested an experimental drug called RZ402 in 94 people with diabetic macular edema, a condition that causes vision loss in people with diabetes. The goal was to see if the drug is safe and can reduce swelling in the retina and improve eyesight compared to a placebo. Par…
Phase 2 • Sponsor: Rezolute • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Breakfast makeover: simple diet change may tame diabetes
Disease control CompletedThis study tested a 4-month online program that encourages a very low-carbohydrate breakfast for adults with poorly controlled type 2 diabetes. Researchers measured how satisfied participants were, how well they stuck to the diet, and changes in blood sugar, weight, and medicatio…
Sponsor: University of Michigan • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New combo therapy shows promise for tough pancreatic cancers
Disease control CompletedThis study tested two different treatment plans for people with a specific type of pancreatic cancer that is on the edge of being removable by surgery. 130 patients received either chemotherapy alone or chemotherapy plus radiation before surgery. The goal was to see which approac…
Phase 2 • Sponsor: Institut de Cancérologie de Lorraine • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Probiotics for pregnant moms may boost baby brain power
Disease control CompletedThis study tests whether giving probiotics to pregnant women with diabetes can improve their babies' brain development. Researchers will give 60 mothers a probiotic supplement and then measure their infants' brain responses to sounds and sights at 1 and 6 months old. The goal is …
Sponsor: University of Minnesota • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Free meals plus heart lessons may lower blood sugar and pressure in underserved communities
Disease control CompletedThis study tests whether adding culturally tailored heart-health education to medically tailored meal programs helps people with type 2 diabetes and high blood pressure eat better and improve their blood sugar and blood pressure. About 176 adults from low-income New York City nei…
Sponsor: Columbia University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can tiny acupuncture needles boost fertility in women with low egg supply?
Disease control CompletedThis study tested whether thumbtack needle acupuncture can improve ovarian function in 240 women aged 18-40 with diminished ovarian reserve (low egg supply). Participants received acupuncture at specific points for up to 4 weeks. The main goals were to see changes in anti-Mülleri…
Sponsor: Dongmei Huang • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New insulin pump software tested in kids as young as 2
Disease control CompletedThis study is checking how safe and effective an updated insulin pump system (Control-IQ 1.5) is for children ages 2 to 6 with type 1 diabetes. About 144 kids will use the pump for a year while researchers track dangerous low blood sugar events and diabetic ketoacidosis. The goal…
Sponsor: Tandem Diabetes Care, Inc. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can 7 days of steroids beat 14 for Alcohol-Related liver disease?
Disease control CompletedThis phase 3 trial compares two steroid schedules for severe alcohol-associated hepatitis, a serious liver condition with high death rates. One group takes prednisolone for 7 days followed by a placebo for 7 days, while the other takes prednisolone for the full 14 days. Researche…
Phase 3 • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a diabetes drug tame PCOS symptoms?
Disease control CompletedResearchers are testing whether sitagliptin, a drug used for diabetes, can improve hormonal, metabolic, and weight-related issues in women with polycystic ovary syndrome (PCOS). The trial will give 80 women with PCOS a 100 mg dose of sitagliptin daily for three months. The main g…
Phase 2/3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can text messages help younger latinx adults tame type 2 diabetes?
Disease control CompletedThis pilot study tests a 12-week text message program called AYUDA for younger Latinx adults recently diagnosed with type 2 diabetes who are also caring for a child. Participants receive twice-weekly texts with diabetes education and self-management resources. Researchers compare…
Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a common diabetes drug reshape blood health in PCOS?
Disease control CompletedThis trial tests whether metformin, a common diabetes drug, changes iron, vitamin B12, and blood parameters in women with polycystic ovary syndrome (PCOS). Women aged 18 to 40 with PCOS receive either metformin or a placebo for six months. Researchers measure metabolic, iron, vit…
Phase 4 • Sponsor: Jerash Private University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a simple fish help tame type 2 diabetes?
Disease control CompletedThis trial asks whether eating tinned mackerel twice a week can improve blood sugar control in South Asian adults with type 2 diabetes. Participants with diabetes will either keep their usual diet or replace some red meat or poultry with mackerel for 16 weeks. Researchers will me…
Sponsor: University of Aberdeen • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New insulin set aims to last a full week for type 1 diabetes
Disease control CompletedThis study tests a new insulin infusion set designed to last up to 7 days for people with type 1 diabetes. Twenty adults currently using a Tandem insulin pump and Dexcom CGM will try the SteadiSet at home. The goal is to see if the set can survive a full week without causing high…
Sponsor: Tandem Diabetes Care, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Buckwheat drink may tame blood sugar spikes after meals
Disease control CompletedResearchers at the University of Aberdeen are testing whether a buckwheat beverage can reduce blood sugar spikes after meals. The study includes healthy adults and people with type 2 diabetes whose condition is managed by diet or metformin. Participants drink the beverage and hav…
Sponsor: University of Aberdeen • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
A protein supplement may fight fatty liver in teens
Disease control CompletedThis trial tests whether an essential amino acid supplement can lower fat stored in the liver of teenagers with non-alcoholic fatty liver disease (NAFLD). Participants aged 13 to 18 will take the supplement or a placebo for two months, and researchers will measure liver fat with …
Phase 3 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a Two-Drug combo tame a rare nerve and blood disorder?
Disease control CompletedThis phase II trial tests whether the combination of lenalidomide and dexamethasone can help people with POEMS syndrome, a rare blood disorder that damages nerves and causes other symptoms. Participants receive the drug combo either before local radiation or intensive treatment, …
Phase 2 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New pill aims to keep chemo on track for GI cancer patients
Disease control CompletedThis study tests whether avatrombopag, a pill that boosts platelet production, can help people with gastrointestinal cancer who develop low platelets from chemotherapy. About 60 participants will receive either avatrombopag or a placebo. The goal is to see if the drug can raise p…
Phase 2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Tailored diabetes education targets individual complication risks
Disease control CompletedThis trial tests whether personalized education, guided by a risk assessment for six major diabetes complications, can improve blood sugar control in adults with type 2 diabetes. Participants receive education focused on their highest predicted risk, such as kidney disease or str…
Sponsor: Taiwanese Association of Diabetes Educators • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Exercise and education may counter frailty in older diabetics
Disease control CompletedThis trial tests a multimodal program for adults aged 65 and older with type 2 diabetes who are frail or prefrail. The program combines a 16-week exercise routine, educational sessions on diabetes self-care, and adjusted blood sugar and blood pressure goals. Researchers compare t…
Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER) • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Better sleep, better blood sugar? a trial puts sleep coaching to the test
Disease control CompletedMany adults with type 1 diabetes don't get enough sleep, which can make blood sugar harder to control. This trial tests a 12-week program called Sleep-Opt that uses wearable sleep trackers, phone coaching, and educational materials to improve sleep habits. Researchers will measur…
Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a pill tame thyroid eye disease?
Disease control CompletedThis trial tests whether an oral medication called linsitinib can help people with active, moderate to severe thyroid eye disease, a condition that causes eye bulging and inflammation. Participants take either linsitinib or a placebo twice daily for 24 weeks. The main goal is to …
Phase 2/3 • Sponsor: Sling Therapeutics, Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a berry extract tame type 1 diabetes?
Disease control CompletedThis trial tests whether a daily 10-gram dose of sea buckthorn extract, taken for 12 weeks, can improve blood sugar control and immune cell balance in adults with type 1 diabetes. Type 1 diabetes is an autoimmune condition where the body attacks insulin-producing cells. The study…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a new drug rescue the liver when standard therapy fails?
Disease control CompletedThis phase 2 trial is testing an experimental drug called HTD1801 (BUDCA) in adults with primary biliary cholangitis (PBC) who haven't responded adequately to standard treatment. The goal is to see if the drug can safely lower alkaline phosphatase (ALP) levels, a key marker of li…
Phase 2 • Sponsor: HighTide Therapeutics (Hong Kong) Limited • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can immunotherapy extend remission in Limited-Stage lung cancer?
Disease control CompletedThis trial is investigating whether adding two immunotherapy drugs, nivolumab and ipilimumab, after standard chemotherapy and radiation can help people with limited-stage small cell lung cancer. Even though initial treatment often works well, the cancer frequently returns within …
Phase 2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Could a virtual life-coach program help young adults tame type 1 diabetes?
Disease control CompletedThis study tests a telehealth program called REAL-T, designed to help young adults with type 1 diabetes fit diabetes care into their daily habits and routines. Participants receive about 12 hours of virtual coaching from an occupational therapist over six months. The study compar…
Sponsor: University of Southern California • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could a new drug match the standard for liver cancer treatment?
Disease control CompletedThis trial is testing whether a chemotherapy drug called idarubicin works as well as the standard drug doxorubicin when used in a procedure called transarterial chemoembolization (TACE) for liver cancer. TACE delivers chemotherapy directly to the tumor and blocks its blood supply…
Phase 2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a Once-Monthly shot tame Acromegaly's hormone overdrive?
Disease control CompletedThis trial is testing whether a new, once-monthly injection of octreotide (CAM2029) can help people with acromegaly, a condition where the body makes too much growth hormone. Participants will receive either the study drug or a placebo for six months. The main goal is to see if t…
Phase 3 • Sponsor: Camurus AB • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a hormone pill shrink painful ovarian cysts?
Disease control CompletedThis trial tests whether a daily dienogest tablet can shrink endometriomas (ovarian cysts caused by endometriosis) and ease period pain better than a combined oral contraceptive pill. Women aged 18 to 40 with symptomatic endometriomas will take one of the two treatments for three…
Sponsor: Mst.Sumyara Khatun • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
A simple IV fluid choice could tame pancreatitis severity
Disease control CompletedThis trial tests whether the type of IV fluid given to people with acute pancreatitis affects how severe the disease becomes. About 800 adults with acute pancreatitis will be randomly assigned to receive either lactated Ringer's solution or normal saline for at least 48 hours. Th…
Phase 4 • Sponsor: Enrique de-Madaria • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Daily pill could offer new hope for weight loss in east asian adults
Disease control CompletedThis Phase 3 trial is testing whether a once-daily 50 mg semaglutide tablet can help East Asian adults with overweight or obesity lose weight. Participants will take either the active tablet or a placebo for 68 weeks, alongside lifestyle counseling on diet and physical activity. …
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Ancient herbal recipe put to the test for waning fertility
Disease control CompletedThis study looks at whether a traditional Chinese herbal formula, Guishen Yijing, can help women with diminished ovarian reserve (DOR) — a condition where the ovaries have fewer eggs than expected for a woman's age. Researchers will review medical records of 126 women who took th…
Sponsor: Shi Yun • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Can a hormone drug shrink painful ovarian cysts better than the pill?
Disease control CompletedThis trial tests whether elagolix, a hormone-blocking drug, can shrink endometriomas (ovarian cysts caused by endometriosis) and ease severe period pain better than the combined birth control pill. Women aged 18-40 with symptomatic endometriomas (2-5 cm) will take either elagolix…
Sponsor: Mst.Sumyara Khatun • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Seaweed extract may tackle fatty liver Disease—A trial puts it to the test
Disease control CompletedThis study tests whether a supplement made from brown algae and chromium picolinate, when added to a calorie-controlled Mediterranean diet, can reduce fat buildup in the liver. Adults with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic syndrome wil…
Sponsor: University of Genova • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can heated chemotherapy improve ovarian cancer outcomes?
Disease control CompletedThis trial is testing a procedure called HIPEC, where a heated chemotherapy drug (cisplatin) is delivered directly into the abdomen after surgery to remove visible cancer. The goal is to find the safest dose that can be used in patients with advanced ovarian, fallopian tube, or p…
Phase 1 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a targeted antibody calm thyroid eye disease?
Disease control CompletedThis trial tests whether veligrotug, an antibody that blocks a receptor involved in inflammation, can reduce eye bulging and swelling in people with active thyroid eye disease. Participants receive five infusions of the drug or a placebo. The study measures how many people see a …
Phase 3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a single pill tackle both fatty liver and diabetes?
Disease control CompletedThis trial tests an experimental oral drug called HTD1801 in adults with nonalcoholic steatohepatitis (NASH), a serious liver condition, along with liver fibrosis and type 2 diabetes or prediabetes. Participants receive either HTD1801 or a placebo to see if the drug can improve l…
Phase 2 • Sponsor: HighTide Therapeutics (Hong Kong) Limited • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a higher dose of letrozole unlock fertility for women with PCOS?
Disease control CompletedThis trial is testing whether a higher dose of the fertility drug letrozole (10 mg) works better than the standard lower dose (5 mg) for stimulating ovulation in infertile women with polycystic ovary syndrome (PCOS). About 86 women aged 18-35 with PCOS will take one of the two do…
Sponsor: Mst.Sumyara Khatun • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a common diabetes drug reshape PCOS metabolism?
Disease control CompletedThis trial follows women with polycystic ovary syndrome (PCOS) who take metformin, a standard diabetes medication, for six months. Researchers track changes in insulin resistance, iron levels, erythropoietin, cholesterol, and blood counts at three and six months. The goal is to s…
Phase 4 • Sponsor: Jerash Private University • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Smart insulin pump aims to end dangerous nighttime blood sugar swings
Disease control CompletedThis trial tests a smart insulin pump algorithm designed to automatically adjust insulin delivery during the night to keep blood sugar levels in a safe range. The algorithm predicts when blood sugar might drop too low and pauses insulin, and when it might rise too high, it gives …
Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a higher starting dose of thyroid hormone speed up recovery in newborns?
Disease control CompletedThis trial tests whether a higher starting dose of levothyroxine, a thyroid hormone replacement, helps newborns with congenital hypothyroidism reach normal thyroid function faster than a moderate dose. About 100 full-term infants diagnosed at birth are randomly assigned to one of…
Phase 4 • Sponsor: Menoufia University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a traditional herbal remedy tame type 2 diabetes?
Disease control CompletedThis trial investigates whether a traditional herbal drug, NOSHIN SHAHD, can improve insulin resistance and reduce inflammation and oxidative stress in people with type 2 diabetes. Participants will take the herbal drug or a placebo for about six weeks, and researchers will measu…
Phase 4 • Sponsor: Kerman Medical University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a Low-Calorie diet and Weight-Loss drug send type 2 diabetes into remission?
Disease control CompletedThis trial tests whether a 12-week calorie-restricted diet, combined with the weight-management drug Contrave, can help people with type 2 diabetes and obesity achieve remission. Remission means blood sugar levels drop below the diabetes threshold without needing glucose-lowering…
Phase 4 • Sponsor: Yeouido St. Mary's Hospital • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a smartphone app tame Alcohol-Related liver disease?
Disease control CompletedThis trial tests whether a digital clinic, delivered through a smartphone app, can improve health outcomes for people with alcohol-associated liver disease (ALD) and alcohol use disorder (AUD). Participants' doctors are randomly assigned to refer them to this digital platform in …
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a Two-Drug combo tame a rare and aggressive gynecologic cancer?
Disease control CompletedThis phase II trial is testing whether the chemotherapy drug eribulin, given alone or combined with the immunotherapy pembrolizumab, can help people with ovarian or uterine carcinosarcoma that has returned or progressed. The study aims to see if these treatments can shrink tumors…
Phase 2 • Sponsor: Australia New Zealand Gynaecological Oncology Group • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a palm oil rival olive Oil's heart benefits?
Disease control CompletedThis trial asks whether cooking with refined high-oleic palm oil can improve cholesterol and blood sugar levels as effectively as olive oil. Healthy adults will be randomly assigned to use one of the two oils in their daily cooking for four months. Researchers will measure change…
Sponsor: Ruby Alejandra Villamil • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can a targeted antibody give pancreatic cancer chemo a boost?
Disease control CompletedThis trial is testing whether adding an experimental antibody called XB2001 to a standard chemotherapy regimen can help people with advanced pancreatic cancer. The study has two parts: first, it finds the safest dose of XB2001, then it compares the antibody plus chemo against a p…
Phase 1/2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a pain block ease lung strain in severe pancreatitis?
Disease control CompletedThis trial tests whether epidural analgesia—pain medicine delivered near the spinal cord—can help people with severe acute pancreatitis breathe better and avoid needing a breathing machine. About 148 ICU patients with severe pancreatitis will be randomly assigned to receive eithe…
Phase 3 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Gamifying exercise: could a phone app outperform traditional programs for obesity and diabetes?
Disease control CompletedThis trial tests whether a smartphone app called Kiplin, which uses games, telecoaching, and social support, can increase daily physical activity in people with obesity or type 2 diabetes. It compares the app to a standard three-month face-to-face exercise program. The main goal …
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
A smarter insulin that aims for the liver could curb dangerous nighttime dips
Disease control CompletedThis trial tests whether a specially designed mealtime insulin, HDV-insulin lispro, can reduce nighttime low blood sugar (hypoglycemia) in adults with type 1 diabetes. Participants will use continuous glucose monitors and work with doctors to adjust doses. One group receives the …
Phase 2 • Sponsor: Diasome Pharmaceuticals • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a One-Two punch of heat and drainage tame inoperable bile duct cancer?
Disease control CompletedThis trial is testing a personalized treatment for people with inoperable perihilar cholangiocarcinoma, a type of bile duct cancer. The approach combines radiofrequency ablation — using heat to destroy tumor tissue — with complete drainage of bile ducts, guided by both endoscopy …
Sponsor: Clinical Hospital Colentina • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Glucose sensor reveals your personal 'Blood sugar danger Zone' – and a simple fix
Disease control CompletedThis study investigates whether continuous glucose monitor (CGM) data can pinpoint the time of day when a person with prediabetes experiences the largest blood sugar spikes after eating. Participants wear a CGM and activity tracker for 10 days to identify their personal 'vulnerab…
Sponsor: Shifa International Hospital • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
One infusion, two targets: a uric-acid-lowering drug takes aim at heart and kidney disease in youth-onset diabetes
Disease control CompletedThis pilot trial tests whether a single infusion of pegloticase, a drug that breaks down uric acid, can improve markers of heart and kidney health in young men aged 18–25 with youth-onset type 2 diabetes. High uric acid is common in this group and linked to later complications. T…
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Real-Time text messages from your fitness tracker: a new way to fight diabetes?
Disease control CompletedThis trial tests whether a mobile health system that sends real-time text messages—prompting users to take a walk or stand up after sitting too long—can increase physical activity in people with prediabetes or type 2 diabetes. Participants receive a Fitbit tracker and brief advic…
Sponsor: Charles University, Czech Republic • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Bone drugs may double as liver fat fighters — a trial puts them to the test
Disease control CompletedThis trial investigates whether two common osteoporosis medications, denosumab and alendronate, can reduce liver fat and scarring in postmenopausal women who also have nonalcoholic fatty liver disease (NAFLD). The study will compare changes in liver fat and stiffness over 12 mont…
Phase 4 • Sponsor: Aristotle University Of Thessaloniki • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can High-Dose vitamin c boost Chemo's punch against pancreatic cancer?
Disease control CompletedThis trial is testing whether adding high-dose vitamin C (ascorbic acid) to a standard three-drug chemotherapy cocktail can safely and effectively control metastatic pancreatic cancer in people who have not yet received any treatment. The study enrolls adults with stage IV pancre…
Phase 1/2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a cancer pill keep working outside the lab? a Real-World test begins
Disease control CompletedThis study monitors the safety and effectiveness of the drug olaparib (Lynparza) in people with ovarian, breast, prostate, or pancreatic cancer who are prescribed it as part of routine care in South Korea. Researchers will track side effects and how long the cancer stays under co…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a supplement melt liver fat? a trial puts it to the test
Disease control CompletedThis trial is testing whether a special supplement containing silibin, glutathione, and vitamin E can reduce fat buildup in the liver and improve liver function in people with MASLD (a common fatty liver disease linked to metabolism). Over 42 adults, each person will take the sup…
Sponsor: University of Bari • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a new shot help control hepatitis d in people with hepatitis b?
Disease control CompletedThis phase 2 trial is testing whether adding an experimental drug called JNJ-73763989 to standard oral antivirals can better suppress hepatitis D virus in people who are also infected with hepatitis B. About 52 adults with stable chronic co-infection will receive either the combi…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Smartphone app could improve blood sugar control in type 2 diabetes
Disease control CompletedThis study tests whether a connected smartphone app called Health2Sync helps adults with type 2 diabetes who use basal insulin achieve better blood sugar control. The app syncs blood glucose readings and shares them with doctors, who can then adjust insulin doses. Researchers com…
Sponsor: Sanofi • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Drug combo before and after surgery could boost liver cancer outcomes
Disease control CompletedThis study investigates whether combining two drugs—camrelizumab (an immunotherapy) and apatinib (a targeted therapy)—before and after surgery can improve outcomes for people with liver cancer that can be surgically removed. Participants receive the drug combination before surger…
Phase 2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Carb showdown: which diet best controls type 1 diabetes?
Disease control CompletedThis study tests how different amounts of dietary carbohydrates affect insulin needs and blood sugar control in adults with type 1 diabetes. Participants are randomly assigned to one of three diets: a traditional diet with 50-60% of calories from carbs, a moderately low-carb diet…
Sponsor: Anneli Björklund • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a radiofrequency knife beat the stapler for safer pancreas surgery?
Disease control CompletedThis trial tests whether using a radiofrequency device to cut the pancreas during distal pancreatectomy reduces the chance of a pancreatic fistula (a leak of digestive fluids) compared to the standard stapler method. About 112 adults having this surgery for benign or malignant tu…
Sponsor: Patricia Sanchez Velazquez • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can a 12-Week exercise program boost brain and body health in older adults with diabetes?
Disease control CompletedThis study investigates whether a 12-week program combining aerobic and resistance exercise can improve blood sugar control and cognitive function in adults aged 65-79 with type 2 diabetes and mild memory issues. Participants follow a supervised exercise routine that gradually in…
Sponsor: Harbin Sport University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a peer coach help young people take control of their chronic illness?
Disease control CompletedThis study tests whether a peer coaching program delivered by phone and text can help adolescents and young adults (ages 16–22) with chronic conditions like sickle cell disease, diabetes, or cystic fibrosis improve their self-management skills. Participants are paired with a trai…
Sponsor: Duke University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Pharmacy-Based hepatitis c testing could cure more people on opioid therapy
Disease control CompletedThis study tests whether offering hepatitis C testing right in community pharmacies—using a simple finger-prick device—helps more people on opioid therapy get diagnosed and cured compared to the usual approach of referring them to a clinic. Participants are adults on stable metha…
Sponsor: University of Dundee • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a pharmacist check-in boost medication adherence in diabetes and kidney disease?
Disease control CompletedThis study tests a support program for people with type 2 diabetes and chronic kidney failure who struggle to take their medications regularly. Participants receive an electronic pill bottle that tracks when they open it, plus short motivational interviews with a pharmacist. The …
Sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can simple insoles or special exercises restore balance in diabetic nerve damage?
Disease control CompletedThis study tests two approaches to help people with diabetic neuropathy improve their balance. One group uses textured insoles in their shoes, while the other group does a series of quick stretches and compressions called Rood's facilitatory technique. Both groups also receive co…
Sponsor: University of Faisalabad • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Hospital care model aims to treat opioid addiction and serious infections together
Disease control CompletedThis study tests a care model where hospitalized adults with opioid use disorder and a serious infection receive long-acting injectable buprenorphine from their infectious disease doctors, alongside infection treatment. The goal is to keep patients on effective medication for opi…
Sponsor: Yale University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could two kidney drugs together be better than one?
Disease control CompletedThis study investigates whether taking two medications—finerenone and empagliflozin—together can better slow kidney function decline in people with chronic kidney disease and type 2 diabetes compared to taking either drug alone. Participants are randomly assigned to receive the c…
Phase 2 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Low-carb diet may help type 1 diabetes patients keep making some insulin
Disease control CompletedThis study tests whether a low-carbohydrate diet (under 75 grams per day) can help adults with type 1 diabetes preserve their remaining insulin production. The idea is that the diet might calm the immune attack on insulin-making cells. Participants will follow the diet for a peri…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a pill restore sodium balance in patients with hyponatremia?
Disease control CompletedThis phase 3 trial investigates whether the drug tolvaptan can safely and effectively correct low sodium levels in patients with hyponatremia, a condition where the body's sodium-water balance is off. The study enrolls adults with mild to moderate hyponatremia who are either euvo…
Phase 3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can a four-week program boost diabetes tech use in teens?
Disease control CompletedThis study tests a four-week virtual program designed to help teens aged 12-21 with type 1 diabetes use technology like insulin pumps and continuous glucose monitors. Participants complete surveys and interviews about their diabetes management and technology use. The goal is to u…
Sponsor: Stanford University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Diabetes drug dorzagliatin under Long-Term safety watch
Disease control CompletedThis study tracks the long-term safety of dorzagliatin, a drug for type 2 diabetes, in over 2,000 patients over 52 weeks. Researchers monitor side effects and how well the drug controls blood sugar. The goal is to ensure the drug remains safe for everyday use.
Phase 4 • Sponsor: Hua Medicine Limited • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Robotic hip brace may help tame blood sugar spikes after eating
Disease control CompletedThis study tests whether walking with a wearable hip exoskeleton can improve blood sugar control after meals in people with type 2 diabetes. Participants walk for 30 minutes after a meal, either without assistance or wearing the exoskeleton in two different support modes. The goa…
Sponsor: CHA University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a wearable sensor help young people with type 1 diabetes tame blood sugar swings?
Disease control CompletedThis study tests whether using a continuous glucose monitor (CGM) — a small sensor that tracks blood sugar levels in real time — helps teens and young adults (ages 14 to under 25) with type 1 diabetes improve their blood sugar control compared to standard fingerstick testing. Par…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Free meds and tailored education may cut heart risks in Low-Income seniors
Disease control CompletedThis study tests two strategies in low-income seniors with chronic conditions like heart disease, diabetes, or kidney disease. One group gets free preventive medications (no copayment), and another receives personalized education on medication use and lifestyle. The goal is to se…
Sponsor: University of Calgary • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Lab-Made immune protein takes on advanced cancers in first human test
Disease control CompletedThis study tests a new drug called pegilodecakin, a lab-made version of a natural immune protein (interleukin-10), in people with advanced solid tumors such as melanoma, lung, breast, prostate, ovarian, kidney, colorectal, and pancreatic cancers. The drug is given as a daily shot…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can cooking classes and exercise outperform medically tailored groceries for heart and kidney health?
Disease control CompletedThis study tests whether a 3-month community program combining nutrition education, cooking classes, and exercise can improve health outcomes for people with Cardiovascular Kidney Metabolic (CKM) syndrome—a cluster of conditions including diabetes, high blood pressure, high chole…
Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Laser acupuncture shows promise for diabetes body shape
Disease control CompletedThis completed trial tested whether laser acupuncture could improve body shape index (ABSI) in 50 women aged 40-50 with uncontrolled type 2 diabetes and obesity. Participants received either real or sham laser acupuncture twice a week for 12 weeks, plus a low-glycemic diet. The s…
Sponsor: Cairo University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Heart showdown: which diabetes drug shields the heart better?
Disease control CompletedThis large phase 3 trial compares two injectable diabetes medications, tirzepatide and dulaglutide, to see which one better prevents major heart problems like heart attacks, strokes, or death from cardiovascular causes. The study includes over 13,000 adults aged 40 and older with…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Immunotherapy combo targets rare, aggressive lung cancer
Disease control CompletedThis trial investigates whether adding the immunotherapy drug atezolizumab (Tecentriq) to standard chemotherapy (carboplatin and etoposide) helps people with a rare and aggressive lung cancer called large cell neuroendocrine carcinoma (LCNEC). The study enrolls adults with advanc…
Phase 1 • Sponsor: Oncology Center of Biochemical Education And Research • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Doctor training could be key to better diabetes control
Disease control CompletedThis study investigates whether giving endocrinologists (diabetes specialists) a one-week intensive training program helps them manage type 2 diabetes more effectively. The training includes a hospital stay experience and hands-on patient management. Researchers will compare bloo…
Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Engineered virus takes on liver cancer when standard treatment fails
Disease control CompletedThis trial investigates whether JX-594 (Pexa-Vec), a virus modified to attack cancer cells and boost the immune system, combined with best supportive care, can help people with advanced liver cancer live longer. The study enrolls adults whose liver cancer has progressed or who co…
Phase 2 • Sponsor: Jennerex Biotherapeutics • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Diabetes drugs may reverse fatty liver damage in new trial
Disease control CompletedThis study tests whether combining two diabetes drugs—semaglutide and empagliflozin—can reverse liver damage from NASH (a severe form of fatty liver disease) in people with type 2 diabetes. Participants will receive either the combo, empagliflozin alone, or a placebo for 48 weeks…
Phase 4 • Sponsor: German Diabetes Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Brain-like software upgrade helps insulin pumps outsmart diabetes
Disease control CompletedThis study tests a software upgrade for an automated insulin pump system (Control-IQ) in adults with type 1 diabetes. The upgrade adds an adaptive biobehavioral control module that learns from the user's patterns to improve blood sugar management. Participants use the standard sy…
Sponsor: Sue Brown • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Weekly shot could replace daily needles for kids with growth hormone deficiency
Disease control CompletedThis study tests a long-acting growth hormone called TransCon hGH, given as a once-weekly injection, in children with growth hormone deficiency who have already completed a prior TransCon trial. The goal is to see if the weekly shot remains safe and effective over the long term. …
Phase 3 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Weekly shot could replace daily hormone injections for growth hormone deficiency
Disease control CompletedThis phase 3 trial investigates whether a once-weekly injection of lonapegsomatropin, a long-acting growth hormone, can safely and effectively treat adults with growth hormone deficiency. The study compares the weekly drug against a placebo and a standard daily growth hormone pro…
Phase 3 • Sponsor: Ascendis Pharma Endocrinology Division A/S • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Simple stretching program may counteract Diabetes-Related muscle stiffness
Disease control CompletedThis study investigates whether a passive stretching program can reduce muscle and tendon stiffness in people with type 2 diabetes. Diabetes can cause muscles and tendons to become stiffer, making walking harder and increasing energy use. The trial compares stiffness in people wi…
Sponsor: Universita di Verona • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug aims to halt liver scarring in early trial
Disease control CompletedThis study tests an experimental drug called AZD2389 in people with liver fibrosis (scarring) and compensated cirrhosis (early-stage liver damage). The goal is to check the drug's safety and how the body handles it. About 40 adults with liver disease will receive either AZD2389 o…
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a website help cancer survivors live healthier? large study tests online lifestyle coaching
Disease control CompletedThis study tests whether a secure website with educational sessions, goal-setting, and tracking tools can help survivors of several cancers (including breast, prostate, colorectal, and others) improve their diet, increase physical activity, and manage weight. Participants are age…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New daily pill aims to tame type 2 diabetes safely over the long haul
Disease control CompletedThis study tests the long-term safety of an experimental oral drug called orforglipron in adults with type 2 diabetes whose blood sugar is not well controlled by diet, exercise, or other diabetes pills. Participants take the drug once daily for about a year, and researchers monit…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug naderin may help patients fight infections during cancer and TB therapy
Disease control CompletedThis study tested whether adding Naderin (sodium nucleinate) to standard treatment could reduce complications in 75 patients with cancer, tuberculosis, or hepatitis C. The main group received Naderin plus standard therapy, while the control group received standard therapy alone. …
Phase 2/3 • Sponsor: MIPO Clinic • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Immunotherapy duo before liver surgery shows promise against cancer
Disease control CompletedThis trial investigates whether giving two immunotherapy drugs, ipilimumab and nivolumab, before liver surgery can help shrink tumors in people with liver cancer (hepatocellular carcinoma). Participants receive the drugs in the weeks leading up to their planned surgery. The study…
Phase 1/2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
One-Stop health check: can integrated care tame HIV and heart disease together?
Disease control CompletedThis trial tests a package of services called TASKPEN, which combines HIV care with screening and treatment for high blood pressure, diabetes, and tobacco use. It involves over 5,700 adults living with HIV in Lusaka, Zambia. The goal is to see if this integrated approach helps mo…
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Walking your way to better health: smartphone program shows promise for heart and diabetes patients
Disease control CompletedThis study tests whether a three-month smartphone-supported walking program can improve daily step counts, psychological well-being, and body composition in adults with cardiovascular disease or type 2 diabetes. Participants use the Walk15 app to set personalized step goals and t…
Sponsor: Klaipėda University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Poop pills from skinny donors: a new weapon against obesity?
Disease control CompletedThis completed pilot study tested whether transferring gut bacteria from lean donors or from people who had gastric bypass surgery could improve metabolism in 29 obese adults with prediabetes or diabetes. Participants received fecal transplants, and researchers measured changes i…
Sponsor: Wiebke Kristin Fenske • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New diabetes program helps hill tribe elders control blood sugar
Disease control CompletedThis study tested a 6-week diabetes self-management program for ethnic minority elderly (aged 60+) in rural Thailand. The program included weekly group sessions on diet, exercise, medication, and emotional coping, plus two home visits. Researchers measured changes in blood sugar …
Sponsor: Taipei Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
One-Patient trial tests keytruda for rare ovarian cancer
Disease control CompletedThis study tested the drug pembrolizumab (Keytruda) as a follow-up treatment for one patient with a rare type of ovarian cancer called small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). The goal was to see if the drug could help keep the cancer from coming back. Beca…
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New computer tool aims to improve blood sugar control in hospital diabetes patients
Disease control CompletedThis study tested an electronic glucose management system (eGMS) designed to help doctors decide insulin doses for hospitalized patients with type 2 diabetes. The trial compared the eGMS to the usual insulin ordering protocol in 140 patients. The goal was to see if the eGMS could…
Sponsor: Far Eastern Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New cocktail of drugs shows promise for tough bile duct cancer
Disease control CompletedThis study tested a combination of three drugs—camrelizumab, apatinib, and chemotherapy (gemcitabine plus cisplatin)—in 49 people with advanced biliary tract cancer that could not be removed by surgery. The goal was to see if the combo is safe and how well it shrinks tumors. Resu…
Phase 1/2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Robot or scalpel? european trial tests less invasive pancreatic cancer surgery
Disease control CompletedThis trial compares two types of surgery for pancreatic cancer in the body or tail of the pancreas: minimally invasive (laparoscopic or robot-assisted) versus traditional open surgery. The goal is to see if the less invasive approach can remove the tumor just as completely. Adult…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a daily pill replace growth hormone shots for children?
Disease control CompletedThis study tests an oral medication called LUM-201 in children with growth hormone deficiency who have not yet received treatment. The goal is to see if taking a pill daily can improve growth as effectively as standard daily injections. The trial also looks for a way to identify …
Phase 2 • Sponsor: Lumos Pharma • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Mindful eating boosts Low-Carb diet success in type 2 diabetes
Disease control CompletedThis study tested whether adding mindful eating training to a low-carb diet education helps people with type 2 diabetes follow the diet better. About 125 adults were randomly assigned to get either diet education alone or diet education plus mindful eating sessions. The main goal…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Friendly bacteria may help fight gum disease in diabetics
Disease control CompletedThis study tests whether adding a probiotic (Lactobacillus reuteri) to standard deep-cleaning treatment for gum disease can improve gum health and blood sugar levels in adults with diabetes. Participants receive either the probiotic or a placebo (salt water) applied directly into…
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New daily shot could ease rare hormone disorder
Disease control CompletedThis phase 2 trial tested a daily injection called TransCon PTH in 59 adults with hypoparathyroidism, a condition where the body doesn't make enough parathyroid hormone. Participants were randomly assigned to receive either the drug or a placebo for four weeks, followed by an ope…
Phase 2 • Sponsor: Ascendis Pharma A/S • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug combo aims to prevent deadly bowel blockages in ovarian cancer
Disease control CompletedThis completed phase 2 trial tested whether the drug cediranib, given with chemotherapy, is safe for women with advanced ovarian cancer who are at risk of bowel obstruction. 30 participants received the combination. The study focused on whether the treatment caused serious bowel …
Phase 2 • Sponsor: Prof Gordon Jayson • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for liver cancer patients with cirrhosis? tiny trial tests drug duo
Disease control CompletedThis small, completed phase II study tested the safety of combining two drugs—atezolizumab (an immunotherapy) and bevacizumab (a blood vessel blocker)—in 6 people with advanced liver cancer who also had moderate cirrhosis (Child-Pugh B7 or B8). The goal was to see if this treatme…
Phase 2 • Sponsor: Howard S Hochster • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Weekly insulin shot could replace daily injections for diabetes
Disease control CompletedThis study tested a new insulin called icodec, taken just once a week, against a standard daily insulin (degludec) in 588 adults with type 2 diabetes who had never used insulin before. Participants received either weekly icodec plus a daily placebo, or daily degludec plus a weekl…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a daily pill help save sight in diabetic retinopathy?
Disease control CompletedThis study tested an oral medication called APX3330 in 103 adults with moderate to severe diabetic retinopathy, a leading cause of vision loss. The pill aims to reduce inflammation and low-oxygen stress in the eye. Researchers measured whether the drug could improve the severity …
Phase 2 • Sponsor: Ocuphire Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Glucose sensor may flag diabetes risk in cystic fibrosis
Diagnosis CompletedPeople with cystic fibrosis often develop prediabetes and then diabetes, but doctors lack a good way to predict who will progress. This pilot study at Indiana University tests whether a continuous glucose monitor worn for up to 10 days, combined with a mathematical model called t…
Sponsor: Indiana University • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Sound waves may replace the needle in liver scarring tests
Diagnosis CompletedThis study tests whether a sound-wave technique called shear wave elastography, performed during a standard upper endoscopy, can measure liver and spleen stiffness and grade liver fibrosis. Participants are adults with known or suspected cirrhosis who are already scheduled for an…
Sponsor: Providence Medical Research Center • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Diabetes devices put to the test: can home monitors match lab accuracy?
Diagnosis CompletedResearchers are evaluating four blood glucose meters and four HbA1c point-of-care devices to see how accurately they measure blood sugar and long-term glucose control compared with standard lab methods. The study includes people with diabetes, both adults and teenagers, some of w…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Mailing hepatitis c tests home could reach people who avoid clinics
Diagnosis CompletedResearchers in Georgia are testing whether mailing hepatitis C self-tests to people who inject drugs and men who have sex with men increases how many get tested. The trial enrolls 1,250 adults in Tbilisi and Batumi who do not know their hepatitis C status. Half receive a self-tes…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Home hepatitis c tests could reach thousands in pakistan
Diagnosis CompletedResearchers in Karachi, Pakistan, are studying whether delivering hepatitis C self-tests to people's homes increases how many get tested. The trial enrolls about 2,000 adults who live in two areas of the Malir district and have not recently been tested. Half receive a self-test k…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can At-Home hepatitis c tests reach people clinics miss?
Diagnosis CompletedResearchers are testing whether giving people in Malaysia a rapid hepatitis C self-test kit to use at home increases how many get tested, compared with standard clinic-based testing. The trial enrolls 750 adults who are not known to have hepatitis C and have not been tested in th…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Two blood markers put to the test for early liver cancer detection
Diagnosis CompletedResearchers at Hanoi Medical University are studying whether two blood markers, AFP-L3 and PIVKA-II, can accurately detect hepatocellular carcinoma, the most common form of liver cancer. The trial enrolls 200 adults, including people with liver cancer and people with benign liver…
Sponsor: Hanoi Medical University • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can a new ultrasound device spot liver damage without a biopsy?
Diagnosis CompletedResearchers are testing the Liver Incyte system, an ultrasound device that measures how stiff the liver is, to see if it can tell healthy people apart from those with liver fibrosis or steatosis. The trial includes 140 adults, some healthy and some with a history of hepatitis C o…
Sponsor: Sonic Incytes • Aim: Diagnosis
Last updated Sep 17, 2026 00:00 UTC
-
Can a simple home test catch hidden sleep apnea in diabetes?
Diagnosis CompletedThis pilot study explores whether three different home sleep apnea testing devices—NightOwl, SleepImage, and Nox T3—are practical and user-friendly for adults with type 2 diabetes. Participants will wear each device at home for three nights and answer questionnaires about their e…
Sponsor: Zealand University Hospital • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
New device could let surgeons see tissues in real time during gynecological surgery
Diagnosis CompletedThis study tests Cellvizio, a device that provides real-time, high-resolution views of tissues during gynecological surgery. Researchers want to see if it can help diagnose lesions and check surgical margins more accurately. The study will enroll 80 women undergoing laparoscopic …
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Sep 12, 2026 00:00 UTC
-
A simple blood ratio may predict diabetic kidney disease
Diagnosis CompletedResearchers at Assiut University are investigating whether the ratio of two blood proteins, fibrinogen and albumin, is linked to diabetic kidney disease in people with type 2 diabetes. The study compares 50 patients who have both type 2 diabetes and kidney disease with 50 patient…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 11, 2026 00:00 UTC
-
A single blood draw to detect five cancers before symptoms appear?
Diagnosis CompletedThis trial tests a blood-based test designed to detect multiple cancers early in people aged 40 to 74 who have no cancer symptoms. The study will enroll about 2,500 participants and will check how well the test identifies lung, colorectal, liver, gastric, and esophageal cancers. …
Sponsor: Shanghai Weihe Medical Laboratory Co., Ltd. • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
A simple dye might replace radioactive tracers in cancer staging
Diagnosis CompletedThis trial tests whether indocyanine green, a dye injected before surgery, can find sentinel lymph nodes as reliably as the standard technetium-99 radioactive tracer. About 744 adults with various cancers will receive both agents, and surgeons will compare detection rates using a…
Phase 3 • Sponsor: Institut de Cancérologie de Lorraine • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
No more tubes? swallowable capsule could revolutionize stomach acid testing
Diagnosis CompletedThis study tests a new, less invasive way to measure stomach acid using a small wireless capsule (SmartPill) that patients swallow. It compares the capsule's accuracy to the standard method, which involves a tube placed through the nose into the stomach. The study includes health…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
A watchful eye: could alternating scans outsmart pancreatic cancer?
Diagnosis CompletedThis study follows people with a significantly elevated risk of pancreatic cancer—due to inherited gene mutations or strong family history—who choose to undergo early detection testing. Participants receive endoscopic ultrasound (EUS) and MRI scans on an alternating schedule ever…
Sponsor: White Plains Hospital • Aim: Diagnosis
Last updated Aug 27, 2026 00:00 UTC
-
Can a new biopsy needle unlock personalized pancreatic cancer therapy?
Diagnosis CompletedThis trial evaluates a new biopsy needle (Micro-Tech FNB) used during endoscopic ultrasound to collect tissue samples from suspected pancreatic tumors. The goal is to see if this needle provides accurate diagnoses and yields enough high-quality tissue for genetic sequencing, whic…
Sponsor: Radboud University Medical Center • Aim: Diagnosis
Last updated Aug 23, 2026 00:00 UTC
-
A simple blood draw could spot tumor relapse before scans do
Diagnosis CompletedThis study tests whether measuring gene transcripts in the blood can help diagnose neuroendocrine tumors and assess how completely surgery removed them. Researchers will track blood levels after surgery and compare them with imaging to see if a rise in these markers signals tumor…
Sponsor: Wren Laboratories LLC • Aim: Diagnosis
Last updated Aug 23, 2026 00:00 UTC
-
Can sound waves reveal pancreatic cancer without a biopsy?
Diagnosis CompletedThis trial is evaluating whether a specialized ultrasound technique, called shear wave elastography, can accurately identify pancreatic cancer. The study will include 130 adults with a solid pancreatic mass of unknown cause. By measuring tissue stiffness, the technique may help d…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Diagnosis
Last updated Aug 22, 2026 00:00 UTC
-
Can a prostate cancer scan also spot liver tumors?
Diagnosis CompletedThis trial is testing whether a special PET/CT scan, typically used for prostate cancer, can better detect hepatocellular carcinoma (the most common type of liver cancer) compared to standard CT or MRI scans. The study will enroll about 30 adults with liver lesions suspicious for…
Phase 2 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Diagnosis
Last updated Aug 20, 2026 00:00 UTC
-
Could diabetes be silently damaging your hearing?
Diagnosis CompletedThis study investigates whether hearing problems are an under-recognized complication of diabetes. Researchers will screen 172 adults with type 1 or type 2 diabetes using hearing tests and a questionnaire. If a hearing issue is found, a more detailed assessment will be done to de…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
Can a glowing dye reveal a Woman's fertility after ovarian cyst surgery?
Diagnosis CompletedThis trial tests whether a green dye, injected during keyhole surgery to remove benign ovarian cysts, can show how well the ovary is still getting blood flow. The idea is that better blood flow might mean the ovary is healthier and more likely to support a future pregnancy. Women…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
Can a scan replace the needle? ultrasound and MRI put to the test against liver biopsy for fatty liver disease
Diagnosis CompletedThis study investigates whether non-invasive imaging techniques—ultrasound and MRI—can accurately diagnose non-alcoholic steatohepatitis (NASH) and liver fibrosis in people with fatty liver disease. Currently, a liver biopsy is the gold standard, but it is invasive and carries ri…
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Diagnosis
Last updated Jul 26, 2026 00:00 UTC
-
Which liver biopsy needle delivers the best tissue? a Head-to-Head comparison
Diagnosis CompletedThis study compares different ways to take a liver biopsy in adults with chronic liver disease, cirrhosis, or who have had a liver transplant. The goal is to see which method—traditional percutaneous (through the belly) or endoscopic ultrasound-guided (through the stomach)—provid…
Sponsor: University Hospital Muenster • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?
Diagnosis CompletedThis study tests whether the inferior vena cava (the body's main vein) can serve as a reliable reference point for measuring blood pressure in the liver during an endoscopic ultrasound. Normally, doctors use a hepatic vein for this, but in people with advanced liver scarring, tho…
Sponsor: University Hospital Muenster • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
Artificial intelligence spots hidden liver scarring from simple blood tests
Diagnosis CompletedThis study tests a computer program called NIMIT-AI that analyzes routine blood test results over multiple doctor visits to detect liver scarring in people with fatty liver disease (MASLD). Unlike the current standard method (FIB-4), which often misses cases and fails with incomp…
Sponsor: Siriraj Hospital • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC
-
New blood test thresholds could sharpen diagnosis of hidden high blood pressure cause
Diagnosis CompletedThis study looked at 105 people to find the best blood test values for diagnosing primary hyperaldosteronism, a condition where the adrenal glands make too much aldosterone hormone, causing high blood pressure. Researchers measured aldosterone and renin levels using advanced lab …
Sponsor: University Hospital, Caen • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
New device could diagnose fatty liver without needles
Diagnosis CompletedThis study tests whether a device called Fibroscan can diagnose fatty liver disease (steatosis) without needing a biopsy. Researchers will measure liver stiffness and viscosity in 72 people, including healthy volunteers and patients with confirmed fatty liver. Results will be com…
Sponsor: University Hospital, Tours • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple breath test spot hidden diseases early?
Diagnosis CompletedThis study is testing a portable, non-invasive breath analyzer that measures tiny particles in exhaled breath to screen for conditions like type 2 diabetes, liver disease, kidney disease, and lung disease. Researchers will enroll healthy volunteers and people with known diagnoses…
Sponsor: Respyr • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Can cooking classes curb dangerous pregnancy weight gain?
Prevention CompletedWomen with class III obesity who gain too much weight during pregnancy face higher risks of diabetes, high blood pressure, cesarean delivery, and larger babies. Standard prenatal care often does not include nutrition counseling based on weight. This trial tests whether adding gro…
Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Sep 20, 2026 00:00 UTC
-
Can a group program stop eating disorders in type 1 diabetes?
Prevention CompletedResearchers at Stanford University are testing whether the Diabetes Body Project, a six-session group program, can reduce eating disorder symptoms and improve blood sugar control in young women with type 1 diabetes. The study enrolls 55 female-identifying participants aged 15 to …
Sponsor: Stanford University • Aim: Prevention
Last updated Sep 16, 2026 00:00 UTC
-
New approach aims to boost diabetes prevention in underserved communities
Prevention CompletedThis study tested whether adding a special 'pre-session'—which includes education about diabetes risks, motivational interviewing, and help solving barriers—could encourage more people to attend a national diabetes prevention program. The trial involved 483 adults at risk for dia…
Sponsor: Denver Health and Hospital Authority • Aim: Prevention
Last updated Sep 11, 2026 00:00 UTC
-
Extra vaccine dose: could it shield dialysis patients from hepatitis b?
Prevention CompletedThis trial asks whether giving dialysis patients four doses of a double-strength hepatitis B vaccine offers better protection than the standard three doses. People with kidney failure on dialysis often respond weakly to vaccines, leaving many unprotected. The study will compare a…
Sponsor: Jinnah Hospital • Aim: Prevention
Last updated Aug 27, 2026 00:00 UTC
-
Emergency room visit could be a turning point for metabolic health
Prevention CompletedThis pilot trial tests whether a multi-part program given to emergency department patients with metabolic syndrome can encourage more walking and healthier habits. Participants receive a Fitbit, watch a short educational video, get a written exercise prescription, receive text re…
Sponsor: Indiana University • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Can a simple pill or a glue injection stop deadly stomach bleeding?
Prevention CompletedThis trial asks whether endoscopic glue injection or the beta-blocker propranolol is better at preventing the first bleeding episode from gastric varices—enlarged veins in the stomach that can rupture in people with liver cirrhosis. Adults aged 18 to 80 with cirrhosis and gastric…
Phase 4 • Sponsor: Taipei Veterans General Hospital, Taiwan • Aim: Prevention
Last updated Aug 20, 2026 00:00 UTC
-
Could a diabetes prevention strategy also fight heart disease and cancer?
Prevention CompletedThis study follows people at high risk for diabetes who previously took part in a program testing intensive lifestyle changes or the drug metformin. The goal is to see if these approaches can prevent or delay diabetes and reduce long-term health problems like heart disease and ca…
Phase 3 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Prevention
Last updated Aug 01, 2026 00:00 UTC
-
Diabetes drugs may shield against Alzheimer's, massive global study hints
Prevention CompletedThis study analyzes health records from over 2 million adults across five continents to see if GLP-1 receptor agonists (like semaglutide and liraglutide) can lower the risk of developing Alzheimer's disease. It focuses on people aged 40 and older with type 2 diabetes or obesity, …
Sponsor: West China Hospital • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
VR goggles and squeeze balls may take the sting out of insulin shots for seniors
Symptom relief CompletedThis study tested whether watching calming VR videos or squeezing a stress ball could reduce pain, anxiety, and improve satisfaction during insulin injections in older adults (65+) with type 2 diabetes. 90 participants were split into three groups: VR, stress ball, or usual care.…
Sponsor: Tarsus University • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Antioxidant supplement tested as fertility booster for PCOS
Symptom relief CompletedResearchers are testing whether adding alpha-lipoic acid, an antioxidant supplement, to standard letrozole treatment helps infertile women with polycystic ovary syndrome ovulate and become pregnant. The trial enrolls 150 women aged 18 to 35 who are trying to conceive. Both groups…
Phase 3 • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC
-
Can an immune drug slow a rare childhood brain disease?
Symptom relief CompletedAtaxia-telangiectasia is a rare, inherited disease that damages the nervous system, skin, and immune system, and it has no cure. Researchers are testing sirolimus, an immune-suppressing drug, in children under 17 with the condition. The six participants take sirolimus by mouth fo…
Phase 2 • Sponsor: Sara Elva Espinosa Padilla, MD • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
New video program eases Parents' fear of Kids' low blood sugar
Symptom relief CompletedThis study tested a video-based telemedicine program called REDCHiP for parents of young children (ages 2-6) with type 1 diabetes. The program uses education, behavior training, and therapy to reduce parents' fear of hypoglycemia (low blood sugar). 396 families participated, comp…
Sponsor: Nemours Children's Clinic • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Exercise without weight may speed up diabetic foot ulcer healing
Symptom relief CompletedThis study tests whether a 6-week program of non-weight bearing exercise can help diabetic foot ulcers heal faster than standard wound care alone. Forty adults with type 2 diabetes and a foot ulcer will be randomly assigned to exercise plus standard care or standard care only. Re…
Sponsor: University of Michigan • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Which anesthetic is safer for elderly diabetics? new trial aims to find out
Symptom relief CompletedThis study compares two common anesthetics—propofol and sevoflurane—to see which one causes less confusion (delirium) after surgery in older diabetic patients. Researchers will enroll 450 people aged 60 and older undergoing non-cardiac surgery. The goal is to find the best anesth…
Sponsor: Xijing Hospital • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC
-
Magnetic pulses to the sole: a new way to restore feeling in diabetic feet?
Symptom relief CompletedResearchers are testing whether a two-week course of functional magnetic stimulation applied to the sole of the foot can improve feeling, foot strength, balance, and walking in adults with type 2 diabetes and diabetic peripheral neuropathy. Participants are randomly assigned to r…
Sponsor: University of Primorska • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Kitchen foil vs bed sheet: which boosts jaundice treatment best?
Symptom relief CompletedThis study tested whether adding reflective materials like aluminum foil or white cloth around babies during light therapy for jaundice helps lower bilirubin faster. 81 newborns with mild jaundice were randomly assigned to standard therapy, therapy with white cloth reflectors, or…
Sponsor: Kubra Nur Kabakcı Sarıdağ • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Glowing glands: camera may speed up parathyroid surgery
Symptom relief CompletedResearchers test whether a camera called Fluobeam helps surgeons locate parathyroid glands faster during surgery for mild primary hyperparathyroidism. The trial enrolls adults with this condition who need surgery. Half the participants undergo surgery with the camera, and half wi…
Sponsor: Nantes University Hospital • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Can testosterone shield muscle during rapid weight loss?
Symptom relief CompletedBariatric surgery helps people with severe obesity lose weight, but it also strips away muscle and bone. Many men who have the surgery also have low testosterone, which worsens muscle loss. This trial tests whether testosterone replacement, combined with exercise and diet counsel…
Phase 4 • Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Should DKA patients fast or feast? trial tests early eating in the ICU
Symptom relief CompletedDoctors often withhold food from patients being treated for diabetic ketoacidosis in the intensive care unit, but no evidence supports this practice. Researchers are testing whether starting an oral diet early in treatment helps resolve the condition faster and shortens ICU and h…
Sponsor: Texas Tech University Health Sciences Center • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can a pre-surgery spray fix post-op sleep? new trial investigates
Symptom relief CompletedThis study tests whether giving dexmedetomidine—either as a nasal spray or through an IV—before thyroid surgery can improve sleep quality afterward. 120 adults undergoing thyroid removal will be randomly assigned to one of two drug groups or a placebo. The goal is to see if this …
Phase 1/2 • Sponsor: The Second People's Hospital of Huai'an • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can a sleep therapy program help control blood sugar in older diabetes patients?
Symptom relief CompletedResearchers are testing whether cognitive behavioral therapy for insomnia (CBT-I) can improve blood sugar control in older Chinese adults with type 2 diabetes and insomnia. The trial compares CBT-I to usual care in 214 participants aged 60 and older. They will measure changes in …
Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Sep 13, 2026 00:00 UTC
-
Can breathing inside a pyramid ease Diabetes-Related depression?
Symptom relief CompletedPeople with type 2 diabetes often face higher rates of anxiety and depression than the general public. Researchers at Dasman Diabetes Institute are testing whether six weeks of guided breath awareness, practiced inside a pyramid-shaped structure, can reduce those symptoms. The pi…
Sponsor: Dasman Diabetes Institute • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
New combo drug aims to ease nerve pain in diabetes
Symptom relief CompletedThis study tests whether a new medicine called CagriSema can reduce nerve pain in people with type 2 diabetes. About 142 adults with painful diabetic neuropathy will receive either CagriSema or a placebo for around 10 months. The main goal is to see if the drug lowers weekly pain…
Phase 2 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Spleen surgery may reshape cholesterol in cirrhosis
Symptom relief CompletedPeople with liver cirrhosis often have abnormal cholesterol and triglyceride levels. Researchers at Northern Jiangsu People's Hospital are following 150 cirrhosis patients who undergo laparoscopic splenectomy and azygoportal disconnection, a common operation for bleeding caused b…
Sponsor: Northern Jiangsu People's Hospital • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
Ugandan superfoods tested for diabetes control
Symptom relief CompletedThis small study in Uganda looks at how meals made with local fruits and vegetables affect blood sugar and fat levels in people with type 2 diabetes. Eight participants will eat five different test meals over five weeks, with blood samples taken over three hours after each meal. …
Sponsor: KU Leuven • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
Heart failure hope: Anti-Inflammatory drug may reduce need for dangerous heart meds
Symptom relief CompletedThis early-phase study tests whether anakinra, a drug that blocks inflammation, can make the heart more sensitive to inotropes (medicines that strengthen heart contractions) in people with end-stage heart failure. If successful, patients might need lower, safer doses of inotropes…
Phase 1 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Ear zaps may Kick-Start stomach after pancreatic surgery
Symptom relief CompletedThis study tested whether a device that gently stimulates the vagus nerve through the ear could reduce delayed stomach emptying after a major pancreatic surgery (pancreaticoduodenectomy). 84 patients were randomly assigned to receive the stimulation during surgery or not. The goa…
Sponsor: Affiliated Hospital of Nantong University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can a plant compound help control blood sugar? new study explores Quercetin's effects
Symptom relief CompletedThis study looked at whether quercetin, a natural substance found in foods like apples and onions, can change how the body absorbs sugar. Researchers gave 24 obese adults (some with type 2 diabetes) either quercetin or a placebo during a sugar-drink test. They measured blood suga…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Will a tiny sensor boost Well-Being in type 2 diabetes?
Symptom relief CompletedThis study asks whether using a continuous glucose monitor (CGM) — a small sensor worn under the skin that tracks blood sugar levels in real time — can improve quality of life for adults with type 2 diabetes. Participants will use the device for 12 months and complete questionnai…
Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
FitBit coaching may help amputees walk more after surgery
Symptom relief CompletedThis study tests whether a walking program that uses FitBit tracking and personalized coaching can help people who recently had a leg amputation due to diabetes or peripheral artery disease become more physically active. Participants will use a FitBit to monitor their steps and r…
Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Which palliative care approach boosts quality of life in advanced lung cancer?
Symptom relief CompletedThis study looks at two ways of delivering palliative care—specialized support to ease symptoms and stress—for people recently diagnosed with advanced lung cancer. One approach starts with basic palliative care and adds more if needed, while the other provides full palliative car…
Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Thinner needle for thyroid biopsy may reduce pain without sacrificing accuracy
Symptom relief CompletedThis study compares two needle sizes (21-gauge vs 27-gauge) used for ultrasound-guided fine needle biopsy of thyroid nodules. The goal is to see which size causes less pain and discomfort during the procedure while still collecting enough cells for diagnosis. Adults with thyroid …
Sponsor: Izmir Ataturk Training and Research Hospital • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Can a daily pill douse the Sun's pain for people with EPP?
Symptom relief CompletedThis phase 2a trial tests whether an experimental oral drug called PORT-77 can lower levels of protoporphyrin IX (PPIX) in the blood of adults with erythropoietic protoporphyria (EPP). People with EPP experience severe pain and skin reactions after even brief sun exposure. The st…
Phase 2 • Sponsor: Portal Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
Ancient Mind-Body practice tested as fatigue fighter for men after cancer
Symptom relief CompletedThis study investigates whether a 12-week program of tai chi and qigong (called Body Mind Training) can reduce fatigue in male cancer survivors aged 55 and older. Participants are randomly assigned to the mind-body training, a light exercise-only group, or a usual-care group. Res…
Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Simple home workouts may boost strength before liver transplant
Symptom relief CompletedThis study tested whether a personalized home exercise program (walking three times a week and strength training with elastic bands twice a week) could improve fitness and strength in 30 adults waiting for a liver transplant. The goal was to see if better fitness before surgery c…
Sponsor: University Hospital, Limoges • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Morning espresso may Kick-Start digestion after pancreatic surgery
Symptom relief CompletedThis trial investigates whether drinking coffee after pancreatic surgery can help the bowel start working again sooner. About 200 adults who had open pancreatic surgery will receive either regular coffee, decaf coffee, or water twice a day. The main goal is to see how quickly the…
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Hormonal clues may unlock better detection of pregnancy diabetes
Knowledge-focused CompletedThis observational study investigates the role of hormonal and metabolic disorders in the development of gestational diabetes mellitus (GDM). Researchers are analyzing data from over 600 pregnant women to identify risk factors and markers that could predict adverse outcomes for b…
Sponsor: Pirogov Russian National Research Medical University • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Massive study pits tirzepatide against rivals for heart protection
Knowledge-focused CompletedThis completed study looked at insurance claims data from 70,000 people with type 2 diabetes and established heart disease to compare the heart-related risks of three diabetes drugs: tirzepatide, dulaglutide, and semaglutide. The goal was to see if any of these drugs was linked t…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
A blood test for liver trouble may flag hidden risk in sleep apnea patients
Knowledge-focused CompletedResearchers are looking at whether the FIB-4 index, a blood-based score that estimates liver fibrosis risk, tracks with the severity of obstructive sleep apnea (OSA) and low oxygen levels during sleep. They will review records from 373 adults who had full-night sleep studies, gro…
Sponsor: Hisar Intercontinental Hospital • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
New study aims to crack the code of autoimmune diseases
Knowledge-focused CompletedThis study is collecting blood, urine, and stool samples from 500 children with autoimmune diseases and healthy controls. Researchers will analyze these samples to find molecular patterns that could help diagnose these conditions and guide treatment decisions. The goal is to crea…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Hidden muscle loss may affect ovarian cancer treatment
Knowledge-focused CompletedThis study checks for muscle loss (sarcopenia) in 25 women with advanced ovarian cancer before they start chemotherapy. Using CT scans, researchers want to see how common this condition is and if it affects treatment timing. The goal is to better understand how muscle health rela…
Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Glucose monitors may outshine standard test for pregnancy diabetes
Knowledge-focused CompletedThis study looks at whether a continuous glucose monitor (CGM) can provide better insight into blood sugar patterns in pregnant women at risk for gestational diabetes than the usual oral glucose tolerance test (OGTT). Researchers will give 400 high-risk pregnant women a CGM senso…
Sponsor: Portsmouth Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Brown Fat's hidden role in fatty liver disease under investigation
Knowledge-focused CompletedResearchers at Renmin Hospital of Wuhan University are studying whether brown fat activity is linked to nonalcoholic fatty liver disease. They analyze stored PET/CT scans and blood samples from 96 people who had clinically indicated scans. The goal is to find blood proteins that …
Sponsor: Renmin Hospital of Wuhan University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Hidden hepatitis d: nationwide survey maps its reach in thailand
Knowledge-focused CompletedResearchers are surveying people in Thailand who have chronic hepatitis B to find out how many also carry hepatitis D, a virus that can make liver disease worse. The study focuses on groups at higher risk, including people who inject drugs, men who have sex with men, prisoners, a…
Sponsor: The HIV Netherlands Australia Thailand Research Collaboration • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Thyroid troubles tied to weaker muscles and more fatigue in women
Knowledge-focused CompletedThis study looks at how thyroid problems impact pain, tiredness, foot shape, muscle strength, and leg function in women who have regular periods. Researchers will compare 51 women with thyroid issues to healthy women to see what differences exist. The goal is to better understand…
Sponsor: Pamukkale University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Can a liver risk score predict early death from routine checkups?
Knowledge-focused CompletedResearchers at Anhui Provincial Hospital are checking whether an existing risk model can predict five-year death risk in adults with fatty liver disease. The study uses health examination records from nearly 270,000 people seen between 2018 and 2024, including liver ultrasound, e…
Sponsor: Anhui Provincial Hospital • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Family study aims to unlock secrets of hereditary breast and ovarian cancer
Knowledge-focused CompletedThis completed study enrolled 377 individuals and families with a high risk of breast or ovarian cancer due to known or suspected genetic factors. Researchers collected medical records, questionnaires, and biological samples to better understand the disease's natural history and …
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Scientists hunt for testicular cancer genes in families
Knowledge-focused CompletedThis study aims to understand why testicular cancer sometimes runs in families. Researchers will collect DNA samples and medical information from about 750 people in families with multiple cases of testicular cancer. No treatment is given; the goal is to find genes that increase …
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Period power: study reveals how hormones impact blood sugar control
Knowledge-focused CompletedThis study looks at how the menstrual cycle changes blood sugar and energy use in women with type 1 diabetes. About 40 women will use a closed-loop insulin pump and continuous glucose monitor to track these changes. The goal is to understand how hormone shifts affect insulin need…
Sponsor: Lia Bally • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Gut bacteria may worsen liver disease – new study investigates
Knowledge-focused CompletedThis study looked at how bacteria from the gut might travel to the liver and make liver disease worse in people with hepatitis C. Thirty adults with stable liver disease took part. Researchers used blood tests, MRI scans, and liver tissue samples to measure bacterial movement and…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Study maps out tumor detection in rare stomach condition
Knowledge-focused CompletedThis completed study looked at how to best find and manage tumors in people with Zollinger-Ellison syndrome, a rare condition that causes too much stomach acid. Researchers used imaging tests and tissue samples to locate tumors and check for a related genetic condition called MEN…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Hidden hepatitis e threat in transplant patients?
Knowledge-focused CompletedThis study checked how many organ transplant recipients in the U.S. have antibodies to the hepatitis E virus, which can become chronic in people with weakened immune systems. Researchers enrolled 447 adults who had a liver, kidney, or small bowel transplant or were on a waiting l…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can better training get doctors to talk about what matters most to dying veterans?
Knowledge-focused CompletedResearchers are testing two ways to train VA primary care clinicians to hold goals of care conversations with veterans who have serious illnesses such as cancer, heart failure, or dementia. One approach gives clinicians written materials and online training. The other adds team f…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Lifting weights for just 4 weeks may boost breathing muscle and cut liver fat in seniors
Knowledge-focused CompletedThis study looked at whether a 4-week moderate resistance training program could improve diaphragm thickness, liver fat, and quality of life in healthy men aged 60-75. Thirty participants were split into an exercise group or a control group that kept their normal routine. Researc…
Sponsor: Gümüşhane Universıty • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New octreotide pill faces off against current capsule in healthy volunteer study
Knowledge-focused CompletedThis early-stage trial in 18 healthy adults compares a new octreotide tablet (T25) with an existing capsule (MYCAPSSA) to see how much drug gets into the blood. It also checks whether a high-fat meal changes absorption of the tablet. Participants take single doses under fasting o…
Phase 1 • Sponsor: Triastek (Shanghai) Limited • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Fat tissue talks to the ovaries: scientists probe the hidden link
Knowledge-focused CompletedResearchers want to know whether the amount, location, and behavior of body fat contribute to two hormone conditions in women: hypothalamic amenorrhea, where menstrual periods stop, and polycystic ovary syndrome (PCOS). The study enrolls 50 women across five groups, including ath…
Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Robotic surgery vs standard approaches: does the platform change cancer outcomes?
Knowledge-focused CompletedResearchers at a large hospital in Seoul reviewed records from nearly 33,000 adults who had curative-intent surgery for one of seven cancers in the abdomen or pelvis: pancreatic, gastric, rectal, cervical, endometrial, kidney, or prostate. They grouped patients by whether they re…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Fatty liver mystery: could how we process food be the key?
Knowledge-focused CompletedThis study looked at how people with and without non-alcoholic fatty liver disease (NAFLD) process food. Researchers monitored 53 adults over two days, measuring metabolism, blood, and urine after meals. The goal was to find differences that might explain why fat builds up in the…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Blood donors help unlock secrets of hepatitis c
Knowledge-focused CompletedThis study looked at 805 blood donors who tested positive for hepatitis C virus (HCV) to learn how the virus spreads and affects health over time. Researchers collected blood samples and health information to track infection and liver disease. The goal was to better understand HC…
Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Can exercise and diet rewire your cells to fight diabetes?
Knowledge-focused CompletedThis study looked at how different types of aerobic exercise (moderate continuous training vs. high-intensity interval training) and diet counseling affect cell health in people with type 2 diabetes. Researchers measured changes in mitochondria (the cell's power plants) and oxida…
Sponsor: University of Cadiz • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Liver trouble changes how drugs work: scientists test soticlestat
Knowledge-focused CompletedResearchers are studying how a single oral dose of soticlestat behaves in adults with mild or moderate liver impairment compared with healthy adults. The trial measures drug levels in the blood and tracks side effects over an 8-day clinic stay. The goal is to understand whether l…
Phase 1 • Sponsor: Takeda • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Night eating in pregnancy linked to blood sugar in new study
Knowledge-focused CompletedResearchers at KK Women's and Children's Hospital are studying whether the timing of meals and snacks during pregnancy relates to blood sugar levels. About 300 pregnant women in Singapore, between 18 and 21 weeks gestation, will keep food diaries and use a food record app. The te…
Sponsor: KK Women's and Children's Hospital • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
New fatty liver drug tested in healthy volunteers – no cure expected
Knowledge-focused CompletedThis early-stage study tests a single dose of the experimental drug efimosfermin alfa in 30 healthy adults of Chinese, Japanese, and White/European ancestry. The goal is to check safety, how the body processes the drug, and immune reactions. Participants will not receive any trea…
Phase 1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Massive Pre-Diabetes study seeks clues to stop type 2 diabetes
Knowledge-focused CompletedThis completed study looked at 1759 adults aged 18-55 to uncover why some people develop type 2 diabetes. Researchers measured how the body handles sugar, uses energy, and stores fat, and also collected genetic samples. The goal was to find genetic and lifestyle factors that lead…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Glow-in-the-dark dye may help surgeons spot hidden cancer in kids
Knowledge-focused CompletedThis study is testing whether a green dye called ICG can help surgeons see tumors more clearly during surgery in children and teens with solid tumors. The dye is injected before surgery and makes tumor tissue glow under a special camera. The goal is to see if this technique helps…
Phase 1 • Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
12,000 diabetes records put kidney risk under the microscope
Knowledge-focused CompletedResearchers are examining the medical records of 12,000 people with type 2 diabetes who visited a large diabetes care center in Southern India during 2022 and 2023. The study aims to estimate how many of these patients have kidney insufficiency, a complication that past estimates…
Sponsor: India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
Insulin may quiet the immune alarm tied to heart disease
Knowledge-focused CompletedResearchers at the University at Buffalo are studying whether insulin can reduce inflammation by suppressing toll-like receptors, which are part of the body's immune alarm system. The trial compares insulin infusion with dextrose and saline infusions in three groups: lean healthy…
Sponsor: University at Buffalo • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
AI-Powered trial asks: does adding a second drug cut heart failure risk?
Knowledge-focused CompletedThis study uses computer simulations to compare two treatment strategies for people with chronic kidney disease and type 2 diabetes. Researchers will model whether adding empagliflozin to finerenone reduces heart failure, hospitalizations, and cardiovascular death more than finer…
Sponsor: Aeterna Medical Solutions SL • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Can viral markers predict who survives hepatitis b liver failure?
Knowledge-focused CompletedThis observational study follows people with hepatitis B-related acute-on-chronic liver failure who receive one of three antiviral drugs: entecavir, tenofovir alafenamide, or tenofovir amibufenamide. Researchers measure two newer virological markers, HBV RNA and HBcrAg, over time…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
Blood test may forecast which cirrhosis patients survive after discharge
Knowledge-focused CompletedResearchers are studying whether certain molecules in the blood can predict how well patients with liver cirrhosis will do after leaving the hospital. The trial enrolls adults aged 18 to 80 who were admitted for a serious complication of cirrhosis, such as fluid buildup, confusio…
Sponsor: European Foundation for Study of Chronic Liver Failure • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Spleen surgery and kidney health: a hidden connection in cirrhosis?
Knowledge-focused CompletedPeople with liver cirrhosis and portal hypertension often have kidney problems because of reduced blood flow and fluid buildup. Researchers at one hospital are reviewing medical records of patients who had laparoscopic splenectomy and azygoportal disconnection, a minimally invasi…
Sponsor: Northern Jiangsu People's Hospital • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
New study aims to unlock diabetes mysteries in kazakh adults
Knowledge-focused CompletedThis completed study in Kazakhstan looked at 240 adults recently diagnosed with diabetes. Researchers measured blood sugar, insulin resistance, and immune markers to understand how different forms of diabetes develop. The goal is to help doctors diagnose and treat adult-onset dia…
Sponsor: West Kazakhstan Marat Ospanov Medical University • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Rare disease mystery: NIH launches deep dive into Smith-Magenis syndrome
Knowledge-focused CompletedThis study follows nearly 600 people with Smith-Magenis syndrome (SMS), a rare genetic condition, to track how their health, behavior, and development change over time. Researchers will perform detailed medical exams, genetic tests, and surveys to better understand the syndrome's…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Can brown fat help burn calories? new study investigates
Knowledge-focused CompletedThis study looks at brown adipose tissue (BAT), a type of body fat that may help burn energy and improve metabolism. Researchers want to understand how BAT works and how it changes when people take a drug called mirabegron. The study involves 100 adults aged 18-40 with a BMI betw…
Phase 1 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Can two experimental drugs be used safely in people with cirrhosis?
Knowledge-focused CompletedResearchers are studying how the body handles two experimental drugs, VIR-2218 and VIR-3434, in adults with cirrhosis and liver impairment. Participants receive a single injection of one drug or both together. The trial measures drug levels in the blood and checks for side effect…
Phase 1 • Sponsor: Vir Biotechnology, Inc. • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Mom knows best: using family history to fight disease
Knowledge-focused CompletedThis study looked at whether teaching mothers about their family health history can help them encourage healthier eating and exercise in their families. About 310 adults with at least one child took part. Researchers gave them a Family Health Package with personalized risk info a…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Study checks if past drug still protects kidneys years later
Knowledge-focused CompletedThis study looks at American Indians with type 2 diabetes who had early kidney disease and took a drug called losartan years ago. Researchers want to see if the benefits of that treatment still help protect their kidneys today. About 141 people who were in the earlier study or th…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Blood vessel cells in a simple blood test may predict ovarian cancer therapy success
Knowledge-focused CompletedThis study asks whether measuring circulating endothelial cells (CECs), cells shed from blood vessel walls, can predict how well ovarian cancer patients respond to standard chemotherapy with or without bevacizumab. Researchers will use a standardized flow cytometry method to coun…
Sponsor: Centro di Riferimento Oncologico - Aviano • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Scientists unravel mysteries of puberty and fertility hormone
Knowledge-focused CompletedThis study looked at people with low or no GnRH, a hormone that controls puberty and fertility. Researchers studied 111 adults and teens to understand how GnRH problems affect the body. The goal was to find new hormone patterns and genetic causes, not to test a treatment.
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Can a simple scan reveal hidden liver damage in diabetes patients?
Knowledge-focused CompletedResearchers in Belgium are studying adults with type 2 diabetes to understand how often they develop non-alcoholic fatty liver disease (NAFLD) and what that condition looks like. Participants will undergo a liver scan, provide blood samples, and answer questionnaires about their …
Sponsor: Ziekenhuis Oost-Limburg • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Can a single dose of an antipsychotic disrupt blood sugar control?
Knowledge-focused CompletedThis trial tests whether a single dose of the antipsychotic drugs olanzapine or ziprasidone changes how the body responds to insulin, compared with a placebo. The study enrolls healthy young men who are overweight or have early signs of insulin resistance, but who have never take…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Can cirrhosis make colon polyp removal riskier? a study digs into bleeding rates.
Knowledge-focused CompletedResearchers are reviewing records from 60 people with liver cirrhosis and portal hypertension who had colon polyps removed during a colonoscopy. The goal is to see whether bleeding right after the procedure or in the following days happens more often in this group. The study also…
Sponsor: Zagazig University • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Pre-Pregnancy weight loss may boost Baby's health, study finds
Knowledge-focused CompletedThis study tested whether a very low energy diet (800 calories a day using meal replacements) before pregnancy could improve the health of obese women and their babies. 147 women participated, including those with obesity and healthy-weight women for comparison. Researchers measu…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Can cutting carbs reshape the Body's sugar response?
Knowledge-focused CompletedThis study compares two diets in people with overweight and early signs of blood sugar problems: a low-carbohydrate diet and a Mediterranean diet, both designed to produce similar weight loss. Each participant follows both diets for four weeks, in random order, with a break in be…
Sponsor: Azienda Ospedaliero, Universitaria Pisana • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can a new teaching mix boost Doctors' confidence in endocrine crises?
Knowledge-focused CompletedThis trial tests whether a combined teaching method, which mixes online problem-solving, case discussions, and hands-on scenarios, helps internal medicine residents feel more confident and perform better when managing severe endocrine emergencies like diabetic ketoacidosis and th…
Sponsor: Chaohu Hospital of Anhui Medical University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can software make hospital pharmacists faster and safer?
Knowledge-focused CompletedThis study tests whether a software tool called Synapse Medicine can help hospital pharmacists who work with medical teams make better and faster medication recommendations. The tool analyzes each patient's health information to flag potential drug-related risks, such as harmful …
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can ultrasound spot early joint wear in diabetic nerve damage?
Knowledge-focused CompletedResearchers are using ultrasound to measure the thickness of ankle cartilage in people with type 2 diabetes who have nerve damage, and comparing it with healthy adults. Diabetic polyneuropathy may change how the lower limbs move, which could affect the ankle joint. The study incl…
Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Liver study tests how body handles experimental drug
Knowledge-focused CompletedThis early-stage study looks at how the experimental drug nemtabrutinib is processed in people with moderate liver impairment compared to healthy volunteers. About 32 adults will receive a single oral dose, and researchers will measure drug levels in the blood over time. The goal…
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can a One-Month diet shift diabetes biomarkers?
Knowledge-focused CompletedResearchers at Indonesia University are studying how diet, body measurements, genetic profiles, and blood biomarkers relate to glucose levels in healthy adults. The trial includes 181 participants split into three groups: one follows a balanced diet, one follows a low-carbohydrat…
Sponsor: Indonesia University • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can a nationwide review unlock the secrets of a rare adrenal cancer?
Knowledge-focused CompletedThis study looks back at the medical records of 150 adults in Brazil diagnosed with adrenocortical carcinoma, a rare cancer of the adrenal glands. Researchers will collect details on age, gender, location, tumor stage, hormone activity, and treatments received since the year 2000…
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Healthy volunteers test new MASH drug in early safety trial
Knowledge-focused CompletedThis early-stage study tests the safety and tolerability of a new drug called QL2401 in 70 healthy Chinese adults aged 18 to 45. Participants receive either the drug or a placebo to see how the body handles it. The goal is to gather initial safety data before testing in people wi…
Phase 1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Can doctors predict which children recover slowly after bile duct cyst surgery?
Knowledge-focused CompletedThis study looks back at the medical records of 550 children who had surgery to remove a common bile duct cyst, a condition that can block bile flow and damage the liver. Researchers want to identify which factors, such as age or lab results, are linked to faster recovery of bowe…
Sponsor: Wuhan Children's Hospital • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
Scientists hunt for diabetes genes in west africa
Knowledge-focused CompletedThis study looked at the genes and lifestyle of over 7,400 people in Nigeria to understand why some develop type 2 diabetes. Researchers compared people with and without diabetes to find genetic differences. The goal is to learn more about diabetes causes in African populations a…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Protein 'Fingerprint' blood test could warn of ovarian cancer return
Knowledge-focused CompletedThis study looks at proteins in the blood of women with ovarian, peritoneal, or fallopian tube cancer who are in remission. The goal is to find a protein pattern, or 'fingerprint,' that signals when the cancer might come back. Researchers followed 119 women with stage III or IV c…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Study explores how race affects diabetes and heart disease risk in women
Knowledge-focused CompletedThis completed study looked at risk factors for diabetes and heart disease in 146 healthy African, African-American, and white women who were federal employees or contractors. Researchers compared things like triglyceride levels and insulin resistance to see if the best screening…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New study explores Weight's hidden impact on daily life in diabetes
Knowledge-focused CompletedThis study looks at how body weight influences physical activity, balance, and quality of life in 50 adults with type 2 diabetes. Researchers will measure body composition, muscle strength, walking ability, and balance using simple tests and questionnaires. The goal is to better …
Sponsor: Bezmialem Vakif University • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Vitamin e study aims to uncover how body fat affects nutrient needs in women
Knowledge-focused CompletedThis completed Phase 1 study looked at how vitamin E is absorbed and used in the bodies of normal-weight and obese women, and whether vitamin C helps. Fifty women aged 18 to 40 took part, including some with type 2 diabetes. Researchers gave different doses of vitamin E (by mouth…
Phase 1 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can a T-Cell signature unlock the secrets of autoimmune liver disease?
Knowledge-focused CompletedThis study aims to identify the unique molecular signature of immune cells called T cells that mistakenly attack the liver in autoimmune liver diseases like autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis. Researchers will analyze blood sampl…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Scientists investigate why adrenal tumors produce hormones
Knowledge-focused CompletedThis study looked at adrenal gland tumors to understand why they form, why some release extra hormones, and why some are cancerous. Researchers studied 690 people with known or suspected adrenal tumors. Participants underwent tests like blood draws, imaging scans, and urine colle…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
HIV drug side effects: new study probes liver damage risk
Knowledge-focused CompletedThis study looked at liver fibrosis (scarring) in 127 HIV patients who had high liver enzymes while on antiretroviral therapy. Participants underwent tests like liver biopsy, ultrasound, and CT scans to measure liver damage. The goal was to understand how common and severe liver …
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Family talk could be key to preventing disease in Mexican-American communities
Knowledge-focused CompletedThis study examined how Mexican-American families discuss their risk for diabetes, heart disease, breast cancer, and colon cancer. Researchers interviewed 498 adults from Mexican-American households in Houston to understand how culture and family history influence health communic…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Stomach sensor may unmask hidden effects of weight-loss drugs
Knowledge-focused CompletedThis study tests whether a non-invasive device called Gastric Alimetry can detect changes in stomach muscle activity caused by semaglutide (Ozempic). Researchers will measure stomach electrical signals and symptoms in people with and without diabetes before and after taking the w…
Sponsor: University of Western Sydney • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Family secrets? study maps how relatives talk about genetic health risks
Knowledge-focused CompletedThis study explored how family members share health information about genetic diseases like sickle cell, diabetes, and cancer. Over 1,000 adults completed surveys or interviews about their family health history and support. The goal was to understand social and relational factors…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Can patient records reveal who will respond to neuroendocrine tumor treatments?
Knowledge-focused CompletedThis study looks back at the medical records of 88 adults with neuroendocrine tumors that have spread or cannot be removed. Researchers will examine how different patient characteristics and treatments relate to overall survival and other outcomes. The goal is to identify factors…
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Can liver scarring predict heart trouble?
Knowledge-focused CompletedResearchers are examining whether liver fibrosis, measured by non-invasive scores, correlates with estimated 10-year cardiovascular risk in adults with metabolic dysfunction-associated steatotic liver disease (MASLD). The study uses data from 271 adults aged 30 to 79 and focuses …
Sponsor: Özgür Bahadır • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Can big data map the burden of Diabetes-Related disability?
Knowledge-focused CompletedThis observational study looks at records from Israel's National Insurance Institute to understand how often diabetes is linked to permanent disability. It will compare disability rates and severity across different regions and over time, from 2020 to 2025. No treatments or tests…
Sponsor: Assuta Medical Center • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
Could being male or female change how a thyroid cancer drug works?
Knowledge-focused CompletedThis study looks at whether men and women with a certain type of advanced thyroid cancer (radioiodine-refractory differentiated thyroid cancer) experience different side effects and outcomes when treated with the drug lenvatinib. Researchers will compare dose reductions, side eff…
Sponsor: Regina Elena Cancer Institute • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
A new tool aims to demystify immunotherapy for advanced cancer patients
Knowledge-focused CompletedThis trial tests whether a 15-minute educational video and a list of suggested questions can improve understanding of immunotherapy among patients with advanced cancer and their caregivers. Participants are randomly assigned to receive the educational materials or usual care, and…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Can we predict kidney damage in young diabetics before it starts?
Knowledge-focused CompletedThis study follows adolescents with youth-onset type 2 diabetes, along with obese and lean peers, into young adulthood to see how their kidneys change over time. Using advanced imaging and kidney function tests, researchers aim to understand early signs of diabetic kidney disease…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Can a new test reveal the immune cells that beat hepatitis c?
Knowledge-focused CompletedThis study aims to develop a new laboratory technique to detect specific immune cells (called CD8 T cells) that target the hepatitis C virus (HCV). Researchers will use blood samples from people infected with HCV genotypes 1 or 4 to test and refine this technique. The goal is to …
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Could artery disease drain the body's repair cells?
Knowledge-focused CompletedThis study is looking at whether peripheral artery disease (PAD) is linked to lower levels of regenerative cells in the blood. Researchers will compare blood samples from adults with PAD to those without the condition, measuring the number of certain progenitor cells and markers …
Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Can hidden heart rhythms explain dialysis risks?
Knowledge-focused CompletedThis study is investigating how often dangerous heart rhythm problems occur in people receiving hemodialysis for end-stage kidney disease. Researchers will implant a small device under the skin to continuously monitor heart rhythm for 18 months in 70 patients, half of whom have d…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Can brain tests unlock the social struggles of turner syndrome?
Knowledge-focused CompletedThis study investigates why some girls with Turner syndrome find it hard to make friends, read emotions, and control their feelings. Researchers will compare 35 girls with Turner syndrome to 35 girls with isolated growth hormone deficiency, all aged 7 to 16. Through puzzles, memo…
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
Could a stress hormone be behind the hidden danger of low blood sugar?
Knowledge-focused CompletedThis study looks at whether adrenaline, the body's stress hormone, triggers an immune reaction during low blood sugar (hypoglycemia) in people with and without type 1 diabetes. Researchers will lower participants' blood sugar and then give drugs that block adrenaline's effects to…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Hidden thyroid cancers: how common are they in patients with thyroiditis?
Knowledge-focused CompletedThis completed study from Minia University looked at 200 patients with autoimmune thyroiditis (an inflamed thyroid) who had thyroid surgery. The goal was to see how often thyroid cancer is found by accident when examining the removed tissue. Researchers checked for cancer in pati…
Sponsor: Minia University • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Could a yellow tinge predict dangerous hospital infections?
Knowledge-focused CompletedThis study looks at whether jaundice, a yellowing of the skin and eyes, makes people with cirrhosis more likely to develop infections while in the hospital. Researchers will follow 250 Egyptian patients with cirrhosis to see if those with jaundice get more hospital-acquired infec…
Sponsor: Tanta University • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
A hidden route for ovarian cancer spread?
Knowledge-focused CompletedThis study investigates whether lymph nodes in the lower abdomen, called the inferior epigastric lymph node basin, might be an early stop for ovarian cancer spreading from the peritoneum. Researchers will biopsy these nodes in 20 patients undergoing surgery for ovarian peritoneal…
Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Could cannabis help fight diabetes? a study investigates
Knowledge-focused CompletedThis study explores whether compounds in cannabis, like THC and CBD, can reduce inflammation and improve how the body responds to insulin. Researchers will measure blood markers of inflammation and insulin sensitivity in people across the weight spectrum, both after a single use …
Sponsor: University of Colorado, Boulder • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
Could hepatitis e be hiding in transplant patients? a screening study aims to find out.
Knowledge-focused CompletedHepatitis E can cause severe liver problems in people who have had an organ transplant, and may become chronic. This study screens liver and kidney transplant patients in Guadeloupe using blood tests to measure how many carry the virus. The goal is to learn whether routine screen…
Sponsor: Centre Hospitalier Universitaire de la Guadeloupe • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Can type 1 diabetes hold kids back from being fit and active? a study aims to find out.
Knowledge-focused CompletedThis study looks at how type 1 diabetes affects the heart, lungs, and overall fitness of children aged 6 to 17. It also measures their physical activity levels and quality of life. Researchers will compare these results with those of healthy children of the same age. The goal is …
Sponsor: Institut Saint Pierre • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Can standard cancer treatment wake up the immune system? a study investigates.
Knowledge-focused CompletedThis study looks at how anti-tumor T-cell responses change in people with lung or head-and-neck cancer who are receiving radiochemotherapy. Researchers will collect blood and tumor samples to track immune markers. The goal is to understand whether this standard treatment can boos…
Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Smartwatch AI may predict liver crisis before symptoms start
Knowledge-focused CompletedThis study tests whether an Apple Watch, combined with artificial intelligence, can detect early signs of improvement or deterioration in people with advanced chronic liver disease (cirrhosis). Participants wear the watch to continuously track heart rate, oxygen levels, sleep, ac…
Sponsor: Antonio Galante • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can a tumor-zapping procedure also wake up the immune system?
Knowledge-focused CompletedThis study looks at how two heat-based procedures — radiofrequency ablation and microwave ablation — affect the immune system in people with small liver cancers. Researchers will take blood samples and tissue biopsies before and after treatment to track changes in immune cells. T…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Customizing electrical current during thyroid surgery could protect vocal cord nerves
Knowledge-focused CompletedThis study investigates whether using a personalized electrical current to monitor the nerve that controls the vocal cords during thyroid surgery is as effective as the standard fixed current. Researchers will analyze data from over 600 patients to see if individualizing the stim…
Sponsor: Medical University of Gdansk • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Ultrasound inside the body reveals how tumors block the bile duct
Knowledge-focused CompletedThis study uses endoscopic ultrasound—a tiny ultrasound probe on a flexible tube passed through the mouth—to measure the size of the common bile duct in people with jaundice caused by pancreatic or bile duct tumors. Researchers aim to better understand how these tumors compress t…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Weight-Loss drugs may offer early liver protection, study suggests
Knowledge-focused CompletedThis study looks at whether two popular weight-loss medications, semaglutide and tirzepatide, can improve early signs of liver damage in people with overweight or obesity. Researchers measured changes in liver health markers after at least 12 weeks of treatment in 154 adults. The…
Sponsor: Goztepe Prof Dr Suleyman Yalcın City Hospital • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Rural health revolution: training future doctors and PAs to collaborate
Knowledge-focused CompletedThis study tests a two-year educational program for medical and physician assistant students in rural areas. The curriculum includes classroom sessions, simulations, and community rotations to improve teamwork skills. Researchers measure changes in knowledge, attitudes, and team …
Sponsor: Pacific Northwest University of Health Sciences • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Blood-Clotting showdown: which device best guides bleeding care in High-Risk patients?
Knowledge-focused CompletedThis study compares three devices that measure how well blood clots — ClotPro, ROTEM, and TEG — in patients undergoing liver surgery, neurosurgery, or cesarean section. The goal is to see how closely the results from these devices agree with each other. The findings may help doct…
Sponsor: Medical University of Vienna • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Artificial intelligence could help guide liver cancer treatment after surgery
Knowledge-focused CompletedThis study developed an artificial intelligence model that analyzes MRI scans and pathology images to predict the risk of liver cancer returning after surgery. Researchers used data from over 500 patients who had their liver cancer surgically removed. The goal is to help doctors …
Sponsor: Anhui Provincial Hospital • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Menstrual cycle forces women with diabetes to hack their insulin pumps
Knowledge-focused CompletedThis study investigates how women with type 1 diabetes manually adjust their automated insulin delivery (AID) systems to manage blood sugar changes during their menstrual cycle. Researchers will interview 69 women to catalog strategies like entering fake carbohydrates or changing…
Sponsor: DCB Research AG • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Could your surroundings trigger a hidden genetic risk?
Knowledge-focused CompletedThis study investigates whether environmental and occupational exposures influence the risk of developing tumors in people who carry an SDHx gene mutation. Researchers will compare two groups of mutation carriers: those who have had a tumor and those who have not. The goal is to …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Could a smartphone replace clinic visits for rare tumor survivors?
Knowledge-focused CompletedThis study tests whether a remote monitoring program can reliably track the health of people who have had surgery for pheochromocytoma or paraganglioma (PPGL), rare adrenal tumors. Participants use an internet platform to report their data, which is compared to information collec…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Blood scores may identify low-risk patients after hepatitis c cure, reducing need for lifelong cancer scans
Knowledge-focused CompletedThis study looks at whether simple, non-invasive blood test scores can predict the risk of developing liver cancer in people with advanced liver disease who have been cured of hepatitis C. Researchers analyzed data from 571 adults treated at a single hospital over ten years. The …
Sponsor: Siriraj Hospital • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Blood protein map may reveal hidden clues in ovarian cancer treatment
Knowledge-focused CompletedThis study looks at how proteins in the blood change in women with ovarian cancer as they go through standard treatment. Researchers collected blood samples before surgery, after surgery, and after chemotherapy to see if these protein shifts could give a fuller picture of how the…
Sponsor: University Medical Centre Ljubljana • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Liver's Post-Meal secrets could unlock new fatty liver treatments
Knowledge-focused CompletedThis study investigates how the liver processes nutrients after a meal in healthy individuals and in patients with fatty liver disease or cirrhosis. Researchers will take blood samples and liver biopsies after fasting or eating a standardized meal, and after a glucagon injection.…
Sponsor: Copenhagen University Hospital, Hvidovre • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Radiation safety study aims to personalize thyroid cancer treatment
Knowledge-focused CompletedThis study collects standard-of-care images from people with differentiated thyroid cancer who are treated with radioactive iodine (Iodine-131). The goal is to better understand how much radiation reaches healthy organs and what dose is needed to destroy thyroid tissue. By gather…
Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Can genes predict liver damage from childhood cancer drugs?
Knowledge-focused CompletedThis study investigates whether certain genetic differences make children with nephroblastoma (kidney cancer) or acute lymphoblastic leukemia (blood cancer) more likely to develop a serious liver condition called hepatic veno-occlusive disease (VOD) during chemotherapy. Researche…
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Race day blood sugar spike: study probes stress effect on athletes with type 1 diabetes
Knowledge-focused CompletedThis study investigates why athletes with type 1 diabetes often experience higher blood sugar during competitions compared to regular training. Researchers will monitor 12 athletes with type 1 diabetes and 12 healthy athletes during a 5K race and a 5K training session, measuring …
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Can a simple training boost diabetes monitor use in underserved communities?
Knowledge-focused CompletedThis study tested whether training healthcare providers to prescribe continuous glucose monitors (CGMs) increases their use among patients with type 2 diabetes. Researchers trained clinic staff at three community health centers serving a mostly Hispanic/Latino population. They th…
Sponsor: San Diego State University • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
New study aims to measure fear of hypoglycemia in french kids with diabetes
Knowledge-focused CompletedThis study tests French versions of three questionnaires that measure fear of low blood sugar (hypoglycemia) in children with type 1 diabetes and their parents. The goal is to ensure these tools are reliable for French-speaking families. About 194 children aged 2 to 18 and their …
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Tilt and pressure test reveals heart secrets in diabetes
Knowledge-focused CompletedThis study looked at how the heart fills and pumps blood when the body is tilted or exposed to lower body pressure. Researchers compared 30 people with type 1 diabetes and healthy volunteers. They used heart monitoring and ultrasound to measure changes, aiming to understand how d…
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Researchers hunt for clues to predict deadly pancreas infection
Knowledge-focused CompletedThis study reviewed medical records of 148 adults admitted to the ICU with severe acute pancreatitis. The goal was to find risk factors for infected pancreatic necrosis, a serious complication that raises the risk of death. By identifying these factors, doctors hope to diagnose a…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Blood test may predict cancer spread in women
Knowledge-focused CompletedThis completed study looked at whether a simple blood test (liquid biopsy) can help track breast, ovarian, and endometrial cancers. Researchers analyzed circulating tumor cells in 150 women to see if these cells could predict the risk of cancer spreading or how well treatment wor…
Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New camera could make cancer treatment safer by better tracking radiation
Knowledge-focused CompletedThis study tested whether a new type of camera (VERITON-CT) can accurately measure radiation doses in patients receiving Lutathera, a treatment for certain cancers. Fifteen adults were scanned with both the new camera and a standard camera at different times after treatment. The …
Sponsor: Central Hospital, Nancy, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Lab study tests antibody that could unlock immune attack on liver cancer
Knowledge-focused CompletedThis completed study looked at a new antibody called anti-SIRPα as a potential immunotherapy for liver cancer. Researchers used blood and tissue samples from 30 liver cancer patients to see how the antibody affects immune cells. The goal was to understand whether blocking the SIR…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Carbs and kids: new study reveals how diet impacts diabetes control with smart pumps
Knowledge-focused CompletedThis study looked at 347 children and teens with type 1 diabetes who use the Medtronic MiniMed 780G insulin pump. Researchers tracked how much carbohydrate they ate each day and measured their blood sugar control over time. The goal was to understand the link between daily carb i…
Sponsor: University of Ljubljana, Faculty of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Phone calls or brochures? study finds best way to get cancer survivors genetic help
Knowledge-focused CompletedThis study looked at two ways to help breast and ovarian cancer survivors get genetic counseling: a mailed brochure or a phone call with a health coach. About 668 women took part. The goal was to see which method led more people to actually get genetic counseling or testing. The …
Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Blood test score may guide ovarian cancer treatment decisions
Knowledge-focused CompletedThis study looks at whether a score called KELIM can predict how well ovarian cancer patients respond to maintenance treatment with PARP inhibitors after initial chemotherapy. Researchers will analyze data from 243 patients who took part in the PAOLA-1 trial. If KELIM proves usef…
Sponsor: ARCAGY/ GINECO GROUP • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Swallowable capsule could unlock secrets of Gut-Liver connection
Knowledge-focused CompletedThis study tests whether a special capsule, called SIMBA, can safely collect fluid from the small intestine in people with liver cirrhosis. Participants swallow two capsules, which are later recovered from stool. Researchers will analyze the fluid to compare gut bacteria and meta…
Sponsor: Vanessa Stadlbauer-Koellner, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
European registry aims to improve care for pancreatic enzyme deficiency
Knowledge-focused CompletedThis study creates a registry of adults with pancreatic exocrine insufficiency (PEI), a condition where the pancreas does not produce enough enzymes to digest food properly. Researchers at eight specialist centers across Europe will track how doctors prescribe pancreatic enzyme r…
Sponsor: Hospital Clinico Universitario de Santiago • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Hepatitis c study tests whether a patient registry is possible in vietnam
Knowledge-focused CompletedThis study looked at whether it's possible to create a group of people with hepatitis C in Hai Phong, Vietnam, for future research. 300 adults with active hepatitis C took part. The goal was to see how many patients could be enrolled and how much information could be collected, n…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Stress hormone link to depression in diabetic children under the microscope
Knowledge-focused CompletedThis study investigates whether stress hormone activity is linked to depression and brain changes in children with type 1 diabetes. Researchers will measure cortisol levels and use brain scans in children aged 6–12 who have had diabetes for at least a year, comparing them to thei…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists explore GLUT1 protein as a diagnostic clue for rare lung tumors
Knowledge-focused CompletedThis study tested whether a protein called GLUT1 could help doctors better classify lung neuroendocrine tumors. Researchers analyzed tumor samples from 36 patients to see if GLUT1 staining patterns matched tumor type. The goal was to find a more reliable diagnostic tool than curr…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
German study reveals Real-World use of PRRT for neuroendocrine tumors
Knowledge-focused CompletedThis study looked at 117 people with gastro-enteropancreatic neuroendocrine tumors (GEP-NETs) who received a type of radiation therapy called PRRT in German clinics. Researchers collected information on patient characteristics, treatment timing, and how PRRT was given in everyday…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Hepatitis b mutations linked to higher virus levels
Knowledge-focused CompletedThis study looks at how certain genetic changes (mutations) in the hepatitis B virus (HBV) affect the amount of virus in the blood of people with chronic infection. Researchers analyzed blood samples from 92 patients not on antiviral treatment. They found that specific mutations …
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC